Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Biochimie. 2014 Feb 21;101:232–247. doi: 10.1016/j.biochi.2014.01.020

Phospholipid Profiles of Control and Glaucomatous Human Aqueous Humor

Genea Edwards a, Katyayini Aribindi a, Yenifer Guerra a, Richard K Lee a, Sanjoy K Bhattacharya a,*
PMCID: PMC3995849  NIHMSID: NIHMS569423  PMID: 24561385

Abstract

To compare phospholipid (phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine and phosphatidylinositol) profiles of human control and glaucomatous aqueous humor (AQH).

AQH samples were procured during surgery from human POAG and control subjects (n=15 each). Samples were used following institutional review board approved protocols and adhering to the tenets of the Declaration of Helsinki. Lipid extraction was performed using a modification of the Bligh and Dyer method, protein concentrations were determined using the Bradford’s method, and select samples were confirmed with Densitometry of PHAST gels. Lipids were identified and subjected to ratiometric quantification using a TSQ Quantum Access Max triple quadrupole mass spectrometer utilizing precursor ion scan (PIS) or neutral ion loss scan (NLS) using appropriate class specific lipid standards in a two step quantification process.

The comparative profiles of phosphatidylcholines, phosphatidylserines, phosphatidylethanolamines and phosphatidylinositols between control and glaucomatous AQH showed several species common between them. A number of unique lipids in all four phospholipid classes were also identified in control eyes that were absent in glaucomatous eyes and vice versa.

A number of phospholipids were found to be uniquely present in control, but absent in glaucomatous AQH and vice versa. Compared with a previous study of control and POAG red blood cells, a number of these phospholipids are absent locally (AQH).

Keywords: lipidomics, mass spectrometry, aqueous humor, glaucoma, phospholipids

1. Introduction

The glaucomas are a group of diseases that cause irreversible blindness frequently associated with an elevated intraocular pressure (IOP). Primary open angle glaucoma (POAG) is one of the most common forms. An estimated 60.5 million people worldwide suffer from glaucoma [1]. Elevation of IOP occurs due to pathologically increased resistance to aqueous humor drainage [2]. Lowering IOP is the only proven strategy for protecting the optic nerve from glaucomatous optic neuropathy. In addition to elevated IOP, diurnal fluctuation in IOP has also been found to be a risk factor for glaucoma development [3]. POAG is most frequently associated with increased elevated IOP [4] and more frequent fluctuation in IOP [3]. The aqueous humor is actively produced by ciliary epithelium [5, 6] and exits through the structures in the anterior chamber [4]. The elevated IOP is thought to be due to impeded outflow. The outflow is reduced in glaucoma due to increased resistance to outflow at the trabecular meshwork (TM), a filter like structure responsible for fluid flow regulation. The exact factor responsible for this increased resistance in the TM in glaucoma is poorly understood. Changes in the TM extracellular matrix (ECM) [7, 8] and the intrinsic elastic modulus of TM both at tissue and cell levels [911] have been demonstrated in glaucoma compared to physiologic conditions.

The main drainage pathway of aqueous humor (AQH) lies in the anterior chamber, which consists of the trabecular meshwork and the Schlemm’s canal [12]. Two mechanisms of lowering IOP are decreasing the production of aqueous humor or increasing the outflow of aqueous humor. Aqueous outflow can be increased through two known pathways – the trabecular meshwork or the conventional, and the uveosceral pathway. A number of pharmacological factors modulate aqueous outflow, for example, β-blockers and carbonic anhydrase inhibitors are known to decrease aqueous humor production. Another group of pharmacological factors, single classes of lipids known as prostaglandins were originally found to exist endogenously. These lipids were discovered in the iris and as a result were named irin [13, 14]. Although they were found to have IOP lowering ability by increasing aqueous humor outflow via the uveoscleral pathway, they also have significant side effects [1318]. Further research into their mechanism of action provided insight into the existence of prostaglandin receptors in the uveoscleral pathway with greater concentration compared to that in the conventional pathway [19].

As noted above, the reason behind increased TM resistance in POAG remains poorly understood. The endogenous factors that regulate TM cell behavior and homeostasis also remain poorly understood. Importantly the presence of endogenous lipids in the AQH other than prostaglandins remains to be investigated. TM is constantly bathed in AQH and therefore it is plausible that factors in the AQH may play a modulatory role for TM cell behavior. Existence and the identification of different classes of endogenous lipids in the AQH largely remain to be investigated. A significant compositional change in the AQH may change the state of TM cell behavior and health of TM tissue. Until recently, suitable methods applicable to mixed lipids in very low amounts present in the AQH were critical barriers for their identification and simultaneous quantification. Recent developments in tandem mass spectrometry, bioinformatics and lipid databases have largely eliminated these barriers [2024]. We present the results of profiling for four phospholipids classes namely: phosphatidylcholines (PCs), phosphatidylserines (PSs), phosphatidylethanolamines (PEs) and phosphatidylinositols (PIs) in the aqueous humor and their comparative analyses between glaucomatous and control donors.

2. Materials and methods

2.1 Aqueous Humor Procurement

Control and POAG AQH were procured during glaucoma and cataract surgeries following institutional review board approved protocols and principles outlined in the Declaration of Helsinki were adhered to. A total of 15 control and 15 glaucomatous AQH samples (Supplemental Tables S1 and S2) were included for these studies. All AQH samples were immediately stored at −80°C until time of use. The mean age of donors was 69.8 ± 9.5 years and both genders were included for these studies.

2.2 Lipid Extraction

Aqueous humor samples were subjected to extraction of lipids using suitable and minimal modification of Bligh and Dyer method [25, 26]. The lower organic phase containing the extracted lipids was isolated and solvent dried with a Speed-Vac (Model 7810014; Labconco, Kansas City, MO). Samples were subsequently flushed with argon gas to prevent oxidation. Proteins recovered from the corresponding upper aqueous phase were quantified using Bradford’s method [27]. A subset of protein samples were also subjected to densitometric quantification using bovine serum albumin (BSA) as a standard (amino acid quantified) after electrophoretic separation on a PHAST (GE Healthcare Bio-Sciences AB, Sweden) gel system [28]. We also repeated protein estimations using an amino acid analyzer after overnight digestion in hydrochloric acid following previously published protocols [29]. The protein amounts determined using amino acid analyzer was utilized in normalization of lipids per amount of proteins. In order to determine and ensure extraction efficiency, ovine wool cholesterol (molecular mass 386.7; catalog no. 700000; Avanti Polar Lipids, Albaster, AL) [30] was premixed with AQH prior to extraction. All extractions and subsequent handling was made using glass vials to avoid contaminating impurities.

2.3 Mass Spectrometric Analysis

A triple quadrupole electrospray mass spectrometer (TSQ Quantum Access Max; Thermo Fisher Scientific, Pittsburgh, PA) was used for analysis of lipids in infusion mode using TSQ Tune software that is part of the Xcaliber 2.3 software package. Extracted lipids were dried and re-suspended in LC-MS grade acetonitrile: isopropanol (1:1). Samples were infused with a flow rate of 10μl/min and analyzed for 1.00 minute with a 0.500 second scan. Scans typically ranged from 200 m/z to 1000 m/z unless specified otherwise. A peak width was set at 0.7 and collision gas pressure was set at 1mTorr. Sheath gas (nitrogen) was set to 20 arbitrary units. Auxiliary gas (Argon) was set to 5 arbitrary units. For analyses of different phospholipid classes collision energy, spray voltage, and ion mode were set based on previous studies [20, 24, 26, 31]. Control and POAG AQH, n=15 each, were utilized for each of the four phospholipid classes analyzed. Class specific lipids were quantified using class specific quantitative lipid standards in two steps [20]. In the first step the most abundant lipids of the class were quantified using a class specific lipid standard and in the second step, the quantification values determined using the first step were used for quantification of the identified low abundant lipid species [20, 24, 26]. The quantification lipid standards (all procured from Avanti Polar Lipids, Albaster, AL) were the same as in our previous study on trabecular meshwork, namely 1,2-ditridecanoyl-sn-glycero-3-phosphocholine (molecular mass 649.89, catalog no. 850340) for PCs, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (molecular mass 810.03, catalog no. 840035) for PSs, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (molecular mass 744.04, catalog no. 850725) for PEs and 1,2-dioleoyl-sn-glycero-3-phospho-(10-myo-inositol) (molecular mass 880.15, catalog no. 850149) for PIs [26]. Quantification lipid standards are different than the lipid standard used for determination and normalization of extraction efficiency. The ovine wool cholesterol (molecular mass 386.7) was used for determination of extraction efficiency as stated above. About 10 scans each with and without internal standard (usually in the range of 0.1– 5 pmol) was performed for each sample. Ratiometric quantification was achieved using the MZmine 2.9 program. Lipid concentration was normalized to protein amount determined from the corresponding aqueous phase as described above.

2.4 Data Analysis

Representative spectra for each sample were carefully and manually inspected by two independent observers from 10 spectra collected for each sample with and without the internal standard (total 30 spectra) and then used for further analyses. Spectra was converted to netCDF files from Thermo RAW files using the Xcalibur 2.3 software suite, subsequently imported into MZmine 2.9 [32], and subjected to noise removal followed by analyses. A selected subset of data was also subjected to analysis in SimLipid version 3.1. The following steps were briefly used for quantification using MZmine 2.9. Thermo RAW files were imported into the MZmine program interface. Original RAW files were retained for future reference. Imported spectra were filtered by the Scan-by-Scan method. Masses were detected in centroid mode and noise levels were removed after the chromatogram was constructed following procedures as described previously [26]. Identification of lipids was achieved using a custom database created from the LipidMaps Database (LMSD). Salient features of phospholipid nomenclature have been presented (Supplemental Table S3). The identification so obtained indicates positions of double bonds and other features of lipids as present in the database and has been retained in our tables. However, our triple quadrupole data cannot verify all the detailed features. Thus, what we indicate in the table are the lipids as found in the database that have been matched by MZmine 2.9. Unique lipids (Table 1) are defined as a given lipid species found in only one group (control AQH or POAG AQH), and with a frequency of ≥ 2 donors. For common lipids species (Tables 25), the presence was recorded in both groups with at least a frequency of ≥ 2 donors in one group. Unique lipid experimental readings (the amount of lipid species) were found to be significantly different from 0.0 by one-sample t-test (P ≤ 0.05). The common lipid species had statistically significant differences between control and POAG AQH by ANOVA. Scheffe’s post hoc test demonstrated a statistically significant difference between control and POAG AQH samples for certain lipid species (P ≤ 0.05).

Table 1.

Unique Phospholipid Species in Control and Glaucomatous Aqueous Humor

m/z* Average lipid amount (pmol per species/μg protein) Donor frequency LIPIDMAPS ID** PUBCHEM ID
Phosphatidylethanolamines

Control Aqueous Humor

PE-NMe2(O-16:0/O-16:0) 692.55 0.002 2 LMGP02040007 14714332
PE(18:1(9E)/18:1(9E)) 743.46 25.085 7 LMGP02010039 14714000

Glaucomatous Aqueous Humor

PE(15:0/20:3(8Z,11Z,14Z)) 727.53 26.092 4 LMGP02010466 123061712

Phosphatidylinositols

Control Aqueous Humor

PI(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) 938.93 0.119 6 LMGP06010555 123065574

Glaucomatous Aqueous Humor

PI(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 884.56 0.008 6 LMGP06010193 123065212
PI(O-18:0/0:0) 587.67 0.003 3 LMGP06060002 123066196
*

A representative mass/charge ratio is presented (variations in m/z was reconciled by MZmine 2.9).

**

The lipid species identification is based on Lipidmaps database, used as a *.csv file for bioinformatic analyses with MZmine 2.9 program. Average standard non-normalized dataset is presented here.

Table 2.

Common lipid species between control and glaucomatous aqueous humor

Control
Glaucoma
Lipid Species* m/z** Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency
PC(10:0/10:0) 565.23 0.028 0.057 5 0.195 0.423 5
PC(10:0/16:0) 649.76 0.894 2.120 7 6.719 11.638 3
PC(10:0/18:0) 677.90 0.010 0.020 7 0.437 1.071 6
PC(10:0/18:1(9Z)) 675.21 0.012 0.009 5 0.005 0.009 5
PC(10:0/18:2(9Z,12Z)) 673.30 0.008 0.015 10 0.004 0.005 6
PC(10:0/19:0) 691.26 0.006 0.007 9 0.640 1.152 4
PC(10:0/20:0) 705.56 0.153 0.331 6 0.237 0.551 7
PC(10:0/21:0) 719.74 0.002 0.004 7 0.004 0.005 2
PC(10:0/22:0) 733.62 0.008 0.009 8 0.270 0.743 8
PC(10:0/23:0) 747.19 0.496 1.359 8 5.536 14.646 7
PC(10:0/24:0) 761.33 0.008 0.011 5 0.294 0.506 3
PC(10:0/25:0) 775.04 17.117 34.117 4 0.458 0.990 8
PC(10:0/4:0) 481.11 0.261 0.612 6 1.311 2.931 5
PC(11:0/11:0) 593.60 0.004 0.008 7 0.180 0.538 9
PC(12:0/12:0) 621.48 0.003 0.006 4 14.901 36.165 6
PC(12:0/13:0) 636.43 0.031 0.008 4 0.911 1.711 4
PC(12:0/14:1(9Z)) 647.62 0.006 0.012 6 0.502 0.870 3
PC(12:0/15:1(9Z)) 661.40 0.001 0.001 4 0.228 0.393 3
PC(12:0/17:2(9Z,12Z)) 687.15 0.013 0.028 8 0.038 0.082 5
PC(12:0/18:1(9Z)) 703.10 1.702 4.492 7 0.140 0.314 5
PC(12:0/18:2(9Z,12Z)) 701.21 0.037 0.078 6 0.172 0.378 5
PC(12:0/18:3(6Z,9Z,12Z)) 699.04 3.420 4.836 2 0.028 0.063 6
PC(12:0/18:4(6Z,9Z,12Z,15Z)) 697.29 0.001 0.001 5 0.097 0.273 8
PC(12:0/20:5(5Z,8Z,11Z,14Z,17Z)) 723.33 0.006 0.007 4 0.060 0.135 5
PC(12:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 750.11 0.002 0.002 2 0.213 0.522 6
PC(12:0/26:0) 817.45 0.019 0.032 7 0.875 1.957 5
PC(13:0/13:0) 651.22 0.001 0.002 2 0.009 0.007 6
PC(13:0/18:2(9Z,12Z)) 714.60 0.004 0.005 4 0.353 0.789 5
PC(13:0/18:3(6Z,9Z,12Z)) 713.31 0.004 0.006 2 2.039 4.078 4
PC(13:0/18:4(6Z,9Z,12Z,15Z)) 711.33 11.139 27.271 6 0.745 1.491 4
PC(13:0/20:3(8Z,11Z,14Z)) 741.47 0.007 0.012 5 0.053 0.127 7
PC(13:0/20:4(5Z,8Z,11Z,14Z)) 739.49 0.798 1.781 5 0.049 0.122 7
PC(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) 737.11 2.261 3.915 3 13.326 15.468 2
PC(13:0/22:2(13Z,16Z)) 771.14 0.428 1.182 8 0.037 0.064 3
PC(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 763.60 0.002 0.003 9 0.307 0.643 6
PC(14:0/18:1(11Z)) 731.37 0.004 0.005 7 0.048 0.120 7
PC(14:0/18:2(11Z,14Z)) 729.05 0.004 0.007 7 0.016 0.031 4
PC(14:0/18:3(9Z,12Z,15Z)) 727.56 0.003 0.006 7 0.731 1.631 5
PC(14:0/18:4(6Z,9Z,12Z,15Z)) 725.53 0.002 0.002 3 15.431 48.654 10
PC(14:0/2:0) 508.81 0.713 1.838 7 0.240 0.480 4
PC(14:0/20:4(5Z,8Z,11Z,14Z)) 753.66 0.021 0.025 8 13.381 23.176 3
PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)) 751.60 0.001 0.002 6 1.32E-04 1.85E-04 4
PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 777.99 0.011 0.021 7 0.054 0.092 5
PC(14:0/24:1(15Z)) 815.21 0.005 0.007 5 18.690 45.082 6
PC(14:0/26:0) 845.82 0.007 0.008 7 0.934 2.088 5
PC(14:1(9Z)/0:0) 464.88 0.209 0.491 6 7.80E-05 7.80E-05 3
PC(15:0/18:1(11Z)) 745.25 0.006 0.011 5 0.124 0.210 6
PC(15:0/18:2(9Z,12Z)) 743.67 0.006 0.011 5 0.316 0.699 5
PC(15:0/20:3(8Z,11Z,14Z)) 769.68 0.001 0.001 4 0.001 0.002 7
PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) 765.03 3.06E-05 4.33E-05 2 0.005 0.005 3
PC(15:0/22:1(11Z)) 801.66 0.731 1.265 3 0.106 0.181 5
PC(15:0/22:2(13Z,16Z)) 799.05 0.002 0.003 5 0.002 0.003 4
PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 791.70 0.002 0.002 5 0.281 0.741 7
PC(15:1(9Z)/0:0) 478.55 0.038 0.074 5 0.295 0.719 6
PC(15:1(9Z)/22:2(13Z,16Z)) 797.36 0.001 0.001 3 0.001 0.002 4
PC(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 793.68 0.014 0.032 7 2.52E-04 2.67E-04 2
PC(16:0/15:1(14)) 717.21 0.008 0.010 7 0.351 0.651 8
PC(16:0/18:1(9Z)) 760.03 0.131 0.339 7 0.327 0.771 6
PC(16:0/18:2(10E,12Z)) 757.25 3.944 10.347 7 0.099 0.140 5
PC(16:0/18:3(6Z,9Z,12Z)) 755.40 0.005 0.011 5 0.001 0.002 5
PC(16:0/2:0) 537.31 31.766 84.034 7 0.291 0.539 8
PC(16:0/20:3(5Z,8Z,11Z)) 784.42 0.023 0.033 2 0.324 0.725 5
PC(16:0/20:4(5Z,8Z,11Z,14Z)) 781.94 0.003 0.005 10 0.789 1.762 5
PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z)) 779.30 0.005 0.011 5 1.47E-04 8.69E-05 5
PC(16:0/22:4(7Z,10Z,13Z,16Z)) 809.88 0.011 0.012 6 16.791 34.734 5
PC(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 807.09 0.012 0.024 7 0.003 0.004 6
PC(16:0/22:6(4E,7E,10E,13E,16E,19E)) 805.07 0.001 0.002 4 0.065 0.118 6
PC(16:0/23:5(8E,11E,14E,17E,20E)) 821.36 0.001 0.002 5 15.670 37.818 6
PC(16:0/24:1(15Z)) 843.44 0.003 0.005 4 0.385 0.483 5
PC(16:0/26:0) 873.72 0.002 0.003 6 0.457 0.725 4
PC(16:0/26:2(5Z,9Z)) 869.19 1.581 3.107 4 0.269 0.568 10
PC(16:0/3:0) 551.33 0.006 0.010 6 0.004 0.008 5
PC(16:0/3:1(2E)) 548.89 0.394 1.168 9 0.079 0.171 5
PC(16:0/5:0(COOH)) 609.52 0.004 0.009 8 0.148 0.441 9
PC(16:0/5:0) 578.94 21.179 56.017 7 0.006 0.008 2
PC(16:0/5:1(4E)) 577.42 0.001 0.002 4 0.001 0.002 7
PC(16:0/9:0(COOH)) 665.49 0.004 0.008 6 0.470 0.938 4
PC(16:1(9E)/0:0) 492.97 0.351 0.681 4 0.020 0.033 3
PC(16:1(9Z)/2:0) 534.97 0.001 0.002 4 4.34E-05 5.07E-05 3
PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 803.05 0.012 0.013 2 0.352 0.861 6
PC(17:0/10:0) 663.62 0.013 0.023 6 0.247 0.650 9
PC(17:0/18:1(9Z)) 773.00 0.003 0.005 8 0.303 0.797 7
PC(17:0/20:4(5Z,8Z,11Z,14Z)) 796.00 0.004 0.009 6 0.407 0.875 6
PC(17:0/22:2(13Z,16Z)) 827.52 0.660 1.603 6 1.076 2.058 4
PC(17:0/22:4(7Z,10Z,13Z,16Z)) 823.75 0.006 0.013 4 9.19E-05 4.94E-05 3
PC(17:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 819.66 0.004 0.008 9 0.001 0.002 4
PC(17:1(10Z)/0:0) 506.81 0.002 0.002 6 0.683 1.183 3
PC(17:1(9Z)/22:2(13Z,16Z)) 825.91 0.008 0.011 2 0.001 0.002 5
PC(17:2(9Z,12Z)/0:0) 505.63 0.004 0.003 4 0.653 1.200 4
PC(18:0/18:0) 789.35 0.005 0.007 9 0.251 0.466 8
PC(18:0/18:1(11Z)) 787.41 0.001 0.001 4 0.327 0.794 6
PC(18:0/18:2(10Z,12Z)) 785.87 0.008 0.017 6 0.001 0.002 4
PC(18:0/20:2(11Z,14Z)) 813.26 0.004 0.005 2 0.113 0.291 7
PC(18:0/20:3(5Z,11Z,14Z)) 811.65 0.002 0.004 6 0.006 0.009 2
PC(18:0/22:3(10Z,13Z,16Z)) 840.05 0.006 0.013 8 0.398 0.787 5
PC(18:0/22:4(7Z,10Z,13Z,16Z)) 837.65 4.358 8.714 4 0.257 0.444 3
PC(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) 835.24 0.004 0.006 6 0.347 0.910 7
PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 833.39 0.004 0.005 6 0.097 0.232 6
PC(18:0/24:1(15Z)) 871.69 0.002 0.004 3 0.003 0.005 5
PC(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 831.52 0.006 0.010 8 0.326 0.722 5
PC(18:1(9E)/2:0) 562.92 7.48E-07 9.94E-07 4 0.083 0.227 10
PC(18:1(9Z)/4:0) 591.03 0.059 0.129 6 0.067 0.131 4
PC(18:2(2E,4E)/0:0) 518.98 0.001 0.003 8 0.002 0.004 4
PC(18:2(9Z,12E)/17:2(9Z,11E)) 767.74 22.423 54.916 6 0.548 0.940 3
PC(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 829.35 0.004 0.007 8 0.419 1.020 6
PC(18:3(9Z,12Z,15Z)/0:0) 516.98 0.006 0.008 7 0.006 0.014 6
PC(18:4(9E,11E,13E,15E)/0:0) 514.66 2.576 5.735 5 0.080 0.121 6
PC(19:0/22:1(11Z)) 856.88 0.006 0.006 6 0.067 0.133 4
PC(19:0/22:2(13Z,16Z)) 855.87 2.40E-04 3.83E-04 3 0.001 0.002 7
PC(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 847.82 0.003 0.007 9 0.205 0.446 7
PC(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 848.70 0.004 0.006 2 6.92E-05 5.39E-05 5
PC(19:3(10Z,13Z,16Z)/0:0) 531.83 4.098 8.468 9 0.602 1.041 8
PC(20:0/20:2(11Z,14Z)) 841.27 0.001 0.001 4 0.261 0.522 4
PC(20:0/22:4(7Z,10Z,13Z,16Z)) 865.66 0.001 0.001 2 0.044 0.109 7
PC(20:0/22:5(7Z,10Z,13Z,16Z,19Z)) 863.72 0.230 0.667 9 0.220 0.532 7
PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 861.72 0.004 0.004 5 0.713 0.980 5
PC(20:0/24:1(15Z)) 899.06 0.014 0.009 2 0.594 1.018 3
PC(20:1(11Z)/22:2(13Z,16Z)) 867.67 2.63E-05 3.60E-05 3 1.16E-05 1.32E-05 4
PC(20:4(5Z,8Z,11Z,14Z)/0:0) 543.05 0.010 0.011 5 0.297 0.782 7
PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) 540.97 5.361 10.714 4 2.534 6.704 7
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)) 853.83 0.001 0.002 7 1.482 2.386 7
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 851.28 3.966 11.205 8 0.620 1.000 6
PC(21:0/22:1(11Z)) 885.21 0.003 0.004 6 0.476 1.064 5
PC(21:0/22:2(13Z,16Z)) 882.82 0.008 0.012 6 0.742 1.285 3
PC(21:0/22:4(7Z,10Z,13Z,16Z)) 879.68 0.003 0.003 6 0.201 0.575 10
PC(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 876.11 0.006 0.007 8 0.506 1.132 5
PC(22:0/22:4(7Z,10Z,13Z,16Z)) 893.46 0.018 0.029 5 0.382 1.074 9
PC(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 890.06 0.002 0.002 6 0.598 1.333 5
PC(22:1(11Z)/22:2(13Z,16Z)) 896.25 0.003 0.005 4 0.003 0.005 6
PC(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 891.42 0.001 0.001 5 0.001 0.001 5
PC(22:1(13E)/22:1(13E)) 896.91 0.017 0.015 2 1.396 2.196 3
PC(22:2(13Z,16Z)/0:0) 574.78 0.008 0.007 5 0.206 0.435 5
PC(22:4(7Z,10Z,13Z,16Z)/0:0) 571.33 35.071 60.745 3 0.373 0.697 8
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) 567.53 1.431 3.196 5 0.909 1.575 3
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 878.23 0.012 0.013 3 0.006 0.015 7
PC(23:0/18:0) 859.57 0.003 0.004 6 0.003 0.006 3
PC(24:0/0:0) 607.61 0.007 0.014 7 0.131 0.244 6
PC(25:0/18:0) 887.91 0.008 0.007 4 0.716 1.709 6
PC(5:0/5:0) 425.12 0.003 0.003 6 0.194 0.397 8
PC(6:0/6:0) 453.41 0.007 0.013 4 0.046 0.096 5
PC(6:2(2E,4E)/6:2(2E,4E)) 445.27 0.004 0.004 5 0.610 1.608 7
PC(6:2(3E,5E)/14:2(11E,13E)) 556.97 17.064 48.247 8 11.401 33.557 9
PC(8:2(2E,4E)/8:2(2E,4E)) 501.42 0.006 0.006 7 0.125 0.333 9
PC(O-10:1(9E)/2:0) 436.97 0.007 0.012 4 0.167 0.400 7
PC(O-11:1(10E)/2:0) 450.87 0.812 1.785 5 0.559 1.408 8
PC(O-12:0/2:0) 467.14 0.898 2.165 6 0.799 1.760 5
PC(O-12:0/O-1:0) 440.00 0.006 0.007 5 1.673 2.729 6
PC(O-14:0/2:0) 495.41 0.005 0.009 4 14.599 29.026 4
PC(O-16:0/2:0) 522.86 1.951 3.109 6 5.254 13.897 7
PC(O-16:1(11Z)/2:0) 520.87 0.001 0.001 3 0.169 0.279 5
PC(O-18:2(9Z,12Z)/2:0) 547.08 0.010 0.007 3 0.0002 0.0001 3
PC(O-8:0/2:0) 411.34 0.024 0.059 9 0.100 0.133 6
*

The lipid species identification is based on Lipidmaps database, used as a *.csv file for bioinformatic analyses with MZmine 2.9 program.

**

A representative mass/charge ratio is presented (variations in m/z was reconciled by MZmine 2.9). Average standard non-normalized dataset is presented here. For some lipid species identified, standard error of mean could not be calculated due to lack of presence in all samples.

Table 5.

Common lipid species between control and glaucomatous aqueous humor

Control
Glaucoma
Lipid Species* m/z** Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency
PI(12:0/0:0) 516.51 0.469 0.802 9 0.042 0.057 6
PI(12:0/12:0) 697.84 0.172 0.326 10 0.132 0.180 4
PI(12:0/13:0) 712.38 0.929 1.798 6 0.249 0.514 7
PI(12:0/14:1(9Z)) 724.47 0.509 1.230 6 0.016 0.037 6
PI(12:0/15:0) 739.76 0.948 2.571 8 0.207 0.307 4
PI(12:0/15:1(9Z)) 738.42 0.640 1.487 10 0.263 0.530 7
PI(12:0/16:1(9Z)) 752.53 1.253 1.565 8 0.092 0.262 9
PI(12:0/17:0) 768.55 0.500 1.195 8 0.113 0.267 7
PI(12:0/17:1(9Z)) 766.08 0.166 0.319 5 0.018 0.046 8
PI(12:0/17:2(9Z,12Z)) 763.79 0.973 1.456 7 0.034 0.061 5
PI(12:0/18:2(9Z,12Z)) 778.44 0.338 0.827 11 0.073 0.110 7
PI(12:0/18:3(6Z,9Z,12Z)) 776.31 1.090 1.219 6 0.036 0.068 5
PI(12:0/18:4(6Z,9Z,12Z,15Z)) 774.82 9.96E-05 3.64E-05 2 0.003 0.002 3
PI(12:0/19:0) 797.12 0.565 1.120 9 0.028 0.041 6
PI(12:0/20:1(11Z)) 807.84 0.389 0.679 7 0.011 0.010 4
PI(12:0/20:2(11Z,14Z)) 806.13 0.398 0.687 6 0.006 0.004 4
PI(12:0/20:3(8Z,11Z,14Z)) 804.40 0.709 1.711 7 0.028 0.061 6
PI(12:0/20:4(5Z,8Z,11Z,14Z)) 801.56 1.649 2.314 2 0.072 0.123 3
PI(12:0/20:5(5Z,8Z,11Z,14Z,17Z)) 800.40 0.004 0.008 6 0.535 1.328 7
PI(12:0/21:0) 824.57 9.953 19.772 6 1.574 3.825 6
PI(12:0/22:2(13Z,16Z)) 833.98 0.005 0.008 5 0.008 0.004 2
PI(12:0/22:4(7Z,10Z,13Z,16Z)) 830.57 0.144 0.296 10 1.109 2.870 7
PI(13:0/0:0) 530.53 0.844 1.610 4 0.109 0.188 5
PI(13:0/17:1(9Z)) 780.45 0.687 0.737 6 0.049 0.064 4
PI(13:0/18:2(9Z,12Z)) 792.24 0.607 1.304 6 0.004 0.006 3
PI(13:0/18:3(6Z,9Z,12Z)) 789.90 0.527 1.215 8 0.003 0.002 7
PI(13:0/18:4(6Z,9Z,12Z,15Z)) 787.95 0.362 0.698 6 0.026 0.054 7
PI(13:0/20:1(11Z)) 822.07 0.135 0.266 6 2.743 7.233 7
PI(13:0/20:2(11Z,14Z)) 820.27 0.222 0.454 6 0.243 0.530 5
PI(13:0/20:3(8Z,11Z,14Z)) 818.10 0.191 0.321 5 0.003 0.003 4
PI(13:0/20:4(5Z,8Z,11Z,14Z)) 816.13 0.607 1.213 6 0.062 0.095 6
PI(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) 814.40 0.452 0.920 6 0.024 0.046 8
PI(13:0/22:0) 852.90 1.583 2.787 6 0.577 1.924 12
PI(13:0/22:1(11Z)) 850.08 0.299 0.304 3 0.052 0.110 7
PI(13:0/22:2(13Z,16Z)) 848.27 0.548 0.846 6 0.006 0.007 7
PI(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 840.47 0.218 0.269 12 0.058 0.110 8
PI(14:0/0:0) 544.13 1.484 1.967 5 1.970 5.066 7
PI(14:0/12:0) 726.85 0.329 0.729 5 0.080 0.168 5
PI(14:0/22:1(11Z)) 864.65 0.076 0.131 4 0.016 0.018 2
PI(14:1(9Z)/0:0) 541.30 0.160 0.292 5 0.002 0.003 6
PI(14:1(9Z)/14:1(9Z)) 750.24 0.719 1.142 8 0.010 0.017 6
PI(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 828.32 0.597 0.876 8 1.552 3.093 8
PI(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 826.62 0.001 0.001 2 0.016 0.017 5
PI(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 856.16 1.126 1.228 4 0.046 0.061 6
PI(15:0/0:0) 558.51 1.089 2.156 5 0.071 0.063 3
PI(15:0/13:0) 754.80 0.630 1.149 7 0.272 0.606 5
PI(15:0/20:3(8Z,11Z,14Z)) 846.70 0.123 0.244 4 0.005 0.008 2
PI(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) 842.70 0.817 1.632 4 0.003 0.003 8
PI(15:0/22:0) 880.05 1.370 1.964 8 0.004 0.003 7
PI(15:0/22:1(11Z)) 878.36 0.002 0.001 2 2.821 6.274 5
PI(15:0/22:2(13Z,16Z)) 876.12 0.691 0.899 6 0.141 0.287 5
PI(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 869.41 1.659 2.556 6 0.005 0.003 6
PI(15:1(9Z)/0:0) 556.01 0.168 0.318 7 1.745 4.605 7
PI(15:1(9Z)/22:2(13Z,16Z)) 874.75 1.233 2.128 3 0.004 0.004 4
PI(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 870.64 0.610 1.050 4 0.001 0.001 2
PI(16:0/0:0) 572.02 1.038 2.116 10 0.308 0.756 7
PI(16:0/16:0) 810.36 0.874 1.208 7 0.178 0.347 4
PI(16:0/18:1(9Z)) 836.92 0.700 0.744 6 0.228 0.473 8
PI(16:0/22:1(11Z)) 892.44 0.198 0.297 5 0.033 0.070 6
PI(16:0/22:2(13Z,16Z)) 890.67 1.089 1.742 6 0.036 0.053 9
PI(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 882.99 1.949 4.284 8 1.177 3.876 11
PI(16:1(9Z)/0:0) 569.31 2.682 4.593 3 0.009 0.015 8
PI(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 854.45 0.193 0.254 4 0.011 0.016 4
PI(16:1(9Z)/22:2(13Z,16Z)) 888.51 1.059 1.751 3 0.004 0.005 5
PI(17:0/0:0) 586.35 0.178 0.353 4 0.099 0.213 8
PI(17:0/14:1(9Z)) 794.91 0.643 0.983 5 1.051 2.565 6
PI(17:0/20:4(5Z,8Z,11Z,14Z)) 872.80 0.643 1.202 7 0.172 0.275 8
PI(17:0/21:0) 894.90 0.924 1.625 7 0.028 0.038 8
PI(17:0/22:1(11Z)) 906.48 0.566 0.908 7 1.062 1.988 8
PI(17:0/22:2(13Z,16Z)) 904.01 0.657 1.307 7 0.009 0.015 5
PI(17:0/22:4(7Z,10Z,13Z,16Z)) 900.86 0.595 1.256 6 0.249 0.725 10
PI(17:1(10Z)/0:0) 584.01 1.239 1.915 10 0.499 1.086 9
PI(17:1(9Z)/22:2(13Z,16Z)) 902.46 0.931 1.265 3 0.012 0.021 5
PI(17:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 897.78 1.740 3.479 4 0.035 0.064 6
PI(17:2(9Z,12Z)/0:0) 581.88 0.115 0.246 7 0.134 0.276 6
PI(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) 896.53 0.573 1.191 6 0.021 0.043 6
PI(18:0/0:0) 600.20 0.248 0.390 3 0.341 0.805 9
PI(18:0/12:0) 783.18 1.554 2.829 7 0.022 0.032 8
PI(18:0/18:0) 866.86 0.805 1.225 5 0.063 0.123 8
PI(18:0/20:4(5Z,8Z,11Z,14Z)) 886.38 0.036 0.077 6 0.077 0.046 3
PI(18:0/22:1(11Z)) 920.30 1.203 1.606 5 0.444 1.149 8
PI(18:0/22:2(13Z,16Z)) 918.37 0.686 1.340 8 0.135 0.291 7
PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 910.80 1.464 3.707 8 0.246 0.585 8
PI(18:1(9Z)/0:0) 597.54 0.362 0.402 3 2.017 4.742 6
PI(18:1(9Z)/22:2(13Z,16Z)) 916.63 0.026 0.044 5 0.027 0.046 6
PI(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 912.70 1.810 3.651 5 4.093 8.146 4
PI(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 908.46 0.383 0.718 8 0.002 0.001 4
PI(18:2(9Z,12Z)/0:0) 596.14 0.528 0.875 5 0.063 0.081 7
PI(18:2(9Z,12Z)/22:2(13Z,16Z)) 914.97 0.795 1.227 6 0.002 0.002 4
PI(18:3(6Z,9Z,12Z)/0:0) 594.17 0.818 1.260 10 0.033 0.069 5
PI(18:4(6Z,9Z,12Z,15Z)/0:0) 591.38 0.047 0.089 6 0.036 0.071 5
PI(19:0/0:0) 614.62 0.018 0.034 7 0.523 1.373 7
PI(19:0/21:0) 922.76 0.836 1.032 5 0.031 0.049 7
PI(19:0/22:0) 936.87 0.050 0.053 5 0.392 1.152 11
PI(19:0/22:1(11Z)) 934.26 0.066 0.136 6 79.176 193.860 6
PI(19:0/22:2(13Z,16Z)) 932.15 0.107 0.164 5 0.109 0.222 8
PI(19:0/22:4(7Z,10Z,13Z,16Z)) 928.73 0.035 0.040 8 1.598 4.208 7
PI(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 924.89 0.025 0.041 8 0.012 0.021 4
PI(19:1(9Z)/0:0) 611.99 1.808 2.323 7 0.850 2.360 10
PI(19:1(9Z)/22:2(13Z,16Z)) 930.51 0.850 1.567 4 0.107 0.227 6
PI(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 926.82 0.125 0.214 3 0.009 0.010 3
PI(20:0/0:0) 628.70 0.129 0.292 9 0.062 0.059 6
PI(20:0/22:1(11Z)) 949.24 0.385 0.754 7 0.021 0.033 5
PI(20:0/22:2(13Z,16Z)) 945.91 0.237 0.309 4 0.602 1.460 6
PI(20:0/22:4(7Z,10Z,13Z,16Z)) 942.74 0.037 0.075 7 0.575 1.358 7
PI(20:1(11Z)/0:0) 625.95 1.264 1.553 4 0.901 2.533 8
PI(20:1(11Z)/22:2(13Z,16Z)) 944.14 0.339 0.385 5 0.005 0.007 5
PI(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 940.12 0.269 0.512 8 0.154 0.271 5
PI(20:2(11Z,14Z)/0:0) 624.28 0.242 0.345 8 0.620 1.561 7
PI(20:3(8Z,11Z,14Z)/0:0) 622.61 1.140 2.421 5 0.006 0.010 5
PI(20:4(5Z,8Z,11Z,14Z)/0:0) 620.43 0.338 0.649 7 0.214 0.400 7
PI(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) 617.91 0.449 0.984 8 0.011 0.016 5
PI(21:0/0:0) 642.11 0.702 1.392 5 0.012 0.020 6
PI(21:0/22:0) 964.57 0.826 1.524 6 0.138 0.163 8
PI(21:0/22:1(11Z)) 962.63 0.796 1.708 7 0.518 0.800 5
PI(21:0/22:2(13Z,16Z)) 959.94 0.067 0.083 6 1.267 3.331 7
PI(21:0/22:4(7Z,10Z,13Z,16Z)) 956.52 0.403 0.788 8 0.047 0.129 9
PI(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 952.51 0.259 0.745 10 2.915 6.635 6
PI(22:0/0:0) 656.83 0.484 0.701 7 0.005 0.005 3
PI(22:0/12:0) 838.44 0.854 1.419 4 0.005 0.007 3
PI(22:0/20:0) 951.05 0.702 1.580 6 0.005 0.005 4
PI(22:0/22:0) 978.93 0.155 0.287 9 0.024 0.038 7
PI(22:0/22:1(11Z)) 976.55 0.599 0.691 8 0.083 0.152 6
PI(22:0/22:2(13Z,16Z)) 974.32 0.404 0.815 9 0.016 0.024 4
PI(22:0/22:4(7Z,10Z,13Z,16Z)) 971.24 0.063 0.093 5 0.044 0.061 6
PI(22:1(11Z)/0:0) 653.48 0.362 0.319 4 0.012 0.018 6
PI(22:1(11Z)/22:2(13Z,16Z)) 973.07 0.080 0.119 4 0.040 0.061 7
PI(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 968.65 0.044 0.074 3 0.015 0.034 9
PI(22:2(13Z,16Z)/0:0) 651.97 0.001 0.001 4 0.271 0.569 7
PI(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)) 1449.58 0.429 0.607 2 0.009 0.015 4
PI(22:4(7Z,10Z,13Z,16Z)/0:0) 647.92 0.522 1.117 5 0.194 0.432 5
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) 644.36 1.142 2.600 8 0.081 0.134 7
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) 958.18 0.008 0.011 2 0.007 0.012 6
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 1145.40 0.774 1.257 5 0.005 0.004 6
*

The lipid species identification is based on Lipidmaps database, used as a *.csv file for bioinformatic analyses with MZmine 2.9 program.

**

A representative mass/charge ratio is presented (variations in m/z was reconciled by MZmine 2.9). Average standard non-normalized dataset is presented here. For some lipid species identified, standard error of mean could not be calculated due to lack of presence in all samples.

3. Results

A representative phosphatidylcholine spectrum for aqueous humor samples from a control (Fig. 1A) and from a POAG donor (Fig. 1B) has been shown. Each of these spectra had a fixed amount (2 pmol) of a lipid standard added normalized to protein amount in the AQH, demonstrating the differences in AQH between the two donors. Total phospholipids in the AQH are reduced by 24.1% in POAG compared to control donor AQH (Table 6). The reduction in total PSs was higher (73.3%) while PCs underwent the least change (2.9%) in POAG compared to control donor AQH. Interestingly, total amount of PEs increased (79.4%) followed by PIs (30.0%) in POAG compared to control (Table 5). Comparison of lysophospholipid to phospholipid ratios between control and glaucomatous AQH (Supplemental Fig. 1) has been shown. The levels of lysophospholipids as a percent of total phospholipids were elevated in POAG AQH (Supplemental Fig. 1A) together with PS and PE in contrast to elevated levels of LysoPC and LysoPI in control AQH (Supplemental Fig. 1B–E).

Figure 1.

Figure 1

Representative electrospray ionization mass spectrometric analysis of the phosphatidylcholine (PC) class of lipids in human aqueous humor (AQH) analyzed in positive-ion mode. (A) Representative spectra of human control and (B) glaucomatous AQH as indicated with internal standard (arrowhead; m/z ratio of 650.6) that has been used for ratiometric quantification. Precursor ion scan for m/z 600–900 has been shown. Arrow shows presence of a unique species in control AQH.

Table 6.

Total Average Protein Normalized Phospholipids in the Aqueous Humor

Phospholipids (pmol/μg protein)
Control Glaucomatous
Phosphatidylcholines 201.427 195.625
Phosphatidylserines 3584.870 956.559
Phosphatidylethanolamines 1615.756 2897.872
Phosphatidylinositols 94.013 122.191
All Phospholipids (total) 5496.066 4172.247

3.1 Phosphatidylcholines of AQH

No unique PC species were found in either control or in POAG AQH (Table 1). The number of common PC species between control and glaucomatous AQH was 152 (Table 2).

3.2 Phosphatidylserines of AQH

No unique PS species were found in either control or in POAG AQH (Table 1). The number of common PS species in AQH was 141 (Table 3).

Table 3.

Common lipid species between control and glaucomatous aqueous humor

Control
Glaucoma
Lipid Species* m/z** Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency
PS(10:0/10:0) 567.38 0.878 2.080 10 5.847 12.149 9
PS(12:0/0:0) 440.94 14.800 43.733 10 5.666 9.098 10
PS(12:0/12:0) 623.47 0.714 1.520 9 6.280 11.708 9
PS(12:0/13:0) 637.56 0.746 1.668 11 5.254 8.527 10
PS(12:0/14:1(9Z)) 649.53 0.868 1.888 9 2.276 5.312 7
PS(12:0/15:0) 665.73 1.692 3.625 8 21.045 53.991 8
PS(12:0/15:1(9Z)) 662.73 6.750 19.875 10 1.388 4.048 10
PS(12:0/16:1(9Z)) 676.97 85.945 253.572 9 53.925 154.644 9
PS(12:0/17:0) 693.70 2.222 4.995 13 4.394 9.066 8
PS(12:0/17:1(9Z)) 691.21 34.288 90.698 7 4.239 8.825 10
PS(12:0/17:2(9Z,12Z)) 688.80 4.995 13.589 9 2.310 5.790 11
PS(12:0/18:2(9Z,12Z)) 703.24 13.098 35.410 8 6.101 11.455 8
PS(12:0/18:3(6Z,9Z,12Z)) 700.64 2.082 3.448 5 2.043 4.324 9
PS(12:0/18:4(6Z,9Z,12Z,15Z)) 698.76 0.512 0.901 10 3.350 8.332 10
PS(12:0/19:0) 722.43 10.936 29.820 8 5.651 9.659 7
PS(12:0/20:1(11Z)) 733.17 0.709 1.566 9 2.976 7.787 11
PS(12:0/20:2(11Z,14Z)) 731.30 28.350 83.670 9 2.088 3.654 7
PS(12:0/20:3(8Z,11Z,14Z)) 729.00 13.816 42.656 10 2.973 8.838 10
PS(12:0/20:4(5Z,8Z,11Z,14Z)) 727.08 1.267 2.733 8 2.021 5.281 11
PS(12:0/20:5(5Z,8Z,11Z,14Z,17Z)) 725.21 0.502 0.915 6 1.817 3.996 12
PS(12:0/21:0) 749.85 24.075 75.376 10 4.193 12.125 10
PS(12:0/22:2(13Z,16Z)) 758.82 15.156 43.647 9 1.405 2.821 8
PS(12:0/22:4(7Z,10Z,13Z,16Z)) 755.54 1.044 2.545 10 5.027 8.563 6
PS(13:0/17:1(9Z)) 705.99 0.598 1.056 8 2.509 4.681 8
PS(13:0/18:2(9Z,12Z)) 717.22 7.906 19.357 10 2.080 5.079 9
PS(13:0/18:3(6Z,9Z,12Z)) 715.14 0.041 0.072 9 2.438 5.357 12
PS(13:0/18:4(6Z,9Z,12Z,15Z)) 713.15 0.170 0.322 10 3.307 5.414 7
PS(13:0/20:1(11Z)) 747.07 0.860 1.964 9 3.103 5.171 7
PS(13:0/20:2(11Z,14Z)) 745.24 0.668 1.098 5 1.270 3.660 11
PS(13:0/20:3(8Z,11Z,14Z)) 742.91 1.566 2.933 7 2.885 5.301 9
PS(13:0/20:4(5Z,8Z,11Z,14Z)) 740.74 20.777 54.213 11 2.353 4.144 8
PS(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) 738.77 0.668 1.550 10 0.885 2.460 11
PS(13:0/22:0) 777.11 17.347 49.697 9 15.830 34.760 7
PS(13:0/22:1(11Z)) 775.30 0.850 1.823 8 4.007 8.601 8
PS(13:0/22:2(13Z,16Z)) 773.21 20.777 50.325 7 3.671 11.110 12
PS(13:0/22:4(7Z,10Z,13Z,16Z)) 769.67 1.161 2.479 8 7.320 17.388 11
PS(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 765.43 1.410 3.216 9 1.750 4.225 14
PS(14:0/0:0) 468.82 0.457 0.811 8 6.397 17.688 9
PS(14:0/12:0) 652.10 0.421 0.885 8 3.463 9.141 12
PS(14:0/14:0) 679.48 1.153 2.283 7 3.961 7.735 9
PS(14:0/20:3(8Z,11Z,14Z)) 757.78 0.005 0.007 4 0.015 0.014 6
PS(14:1(9Z)/0:0) 466.90 0.736 1.483 8 2.549 5.585 12
PS(14:1(9Z)/14:1(9Z)) 674.83 0.367 0.847 10 7.504 13.730 7
PS(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 753.40 23.352 64.524 8 2.149 4.488 11
PS(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 751.27 0.168 0.274 3 0.021 0.035 4
PS(14:1(9Z)/22:2(13Z,16Z)) 785.42 1760.080 3935.379 5 1.333 2.303 5
PS(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 780.78 0.140 0.276 12 0.311 0.619 9
PS(15:0/0:0) 483.48 0.021 0.053 8 5.440 13.711 10
PS(15:0/20:3(8Z,11Z,14Z)) 771.59 0.005 0.007 4 0.024 0.018 2
PS(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) 767.60 369.017 1043.694 8 0.034 0.043 4
PS(15:0/22:1(11Z)) 802.96 0.542 1.304 12 1.830 5.086 8
PS(15:0/22:2(13Z,16Z)) 800.83 0.405 0.827 8 2.370 4.333 9
PS(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 793.95 16.588 48.333 9 5.423 11.206 9
PS(15:1(9Z)/0:0) 481.16 18.588 42.330 9 5.562 12.392 12
PS(15:1(9Z)/22:2(13Z,16Z)) 799.61 0.003 0.003 3 0.013 0.016 6
PS(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 795.41 0.020 0.022 4 0.035 0.048 3
PS(16:0/0:0) 497.31 8.253 23.970 9 5.907 14.433 11
PS(16:0/16:0) 735.08 0.814 1.845 9 5.571 10.996 10
PS(16:0/18:1(11Z)) 761.13 0.971 1.600 7 4.034 8.469 8
PS(16:0/20:0) 791.87 162.053 485.304 9 3.989 8.564 10
PS(16:0/22:1(11Z)) 817.67 0.711 1.852 12 3.467 8.883 11
PS(16:0/22:2(13Z,16Z)) 815.31 4.161 8.664 7 4.711 8.333 7
PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 807.63 17.679 49.747 8 0.150 0.310 11
PS(16:1(9Z)/0:0) 494.32 1.076 2.322 8 2.991 5.302 8
PS(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 779.46 34.773 84.786 6 0.011 0.019 8
PS(16:1(9Z)/22:2(13Z,16Z)) 813.50 3.084 6.891 5 0.009 0.015 4
PS(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 809.09 0.005 0.007 3 0.029 0.066 7
PS(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 805.35 11.054 34.920 10 5.093 11.368 9
PS(17:0/14:1(9Z)) 719.72 1.687 3.632 8 7.171 14.210 10
PS(17:0/20:4(5Z,8Z,11Z,14Z)) 797.57 0.935 1.778 9 3.553 5.509 8
PS(17:0/21:0) 819.81 0.017 0.032 4 1.506 2.399 7
PS(17:0/22:1(11Z)) 830.90 0.400 0.881 11 3.079 6.904 10
PS(17:0/22:2(13Z,16Z)) 828.89 17.808 46.522 7 1.385 3.589 10
PS(17:0/22:4(7Z,10Z,13Z,16Z)) 825.84 1.687 3.150 7 6.191 16.784 13
PS(17:1(9Z)/0:0) 509.25 50.104 86.781 3 0.020 0.025 5
PS(17:1(9Z)/22:2(13Z,16Z)) 827.69 0.031 0.059 5 0.024 0.026 6
PS(17:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 823.17 13.805 43.982 11 0.931 2.144 9
PS(17:2(9Z,12Z)/0:0) 507.32 9.950 27.513 10 6.898 15.157 9
PS(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) 821.74 0.001 0.001 2 0.062 0.046 3
PS(18:0/0:0) 525.73 11.589 22.231 10 5.643 9.924 8
PS(18:0/12:0) 707.97 10.918 37.024 12 1.599 4.547 12
PS(18:0/18:1(9Z)) 789.87 1.802 4.793 11 3.956 8.125 10
PS(18:0/20:4(5Z,8Z,11Z,14Z)) 811.04 0.136 0.238 4 0.062 0.120 4
PS(18:0/22:1(11Z)) 845.83 11.921 30.589 8 6.903 20.371 10
PS(18:0/22:2(13Z,16Z)) 843.43 0.291 0.447 5 3.027 7.061 9
PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 835.41 11.741 25.420 7 9.034 18.750 9
PS(18:1(9Z)/0:0) 523.22 46.424 120.982 9 89.882 240.798 11
PS(18:1(9Z)/18:1(9Z)) 787.11 0.226 0.548 7 0.047 0.017 8
PS(18:1(9Z)/22:2(13Z,16Z)) 840.97 0.237 0.422 10 2.000 6.037 10
PS(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 838.13 13.945 42.847 10 2.202 4.330 9
PS(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 832.87 14.393 42.209 10 3.382 9.863 11
PS(18:2(9Z,12Z)/0:0) 520.97 35.544 98.611 13 305.543 911.091 9
PS(18:2(9Z,12Z)/18:2(9Z,12Z)) 783.43 0.977 2.232 9 2.949 5.459 9
PS(18:2(9Z,12Z)/22:2(13Z,16Z)) 839.87 0.004 0.008 5 0.002 0.001 3
PS(18:3(6Z,9Z,12Z)/0:0) 518.90 24.421 69.571 9 5.038 9.695 5
PS(18:4(6Z,9Z,12Z,15Z)/0:0) 516.77 1.777 5.445 12 1.895 3.576 7
PS(19:0/0:0) 539.96 13.713 44.809 11 1.710 3.411 10
PS(19:0/21:0) 848.05 0.522 1.040 7 1.615 3.494 6
PS(19:0/22:0) 861.16 21.237 67.390 11 3.143 7.865 11
PS(19:0/22:1(11Z)) 859.20 12.994 32.639 8 0.743 1.795 12
PS(19:0/22:2(13Z,16Z)) 857.22 4.585 13.773 10 3.567 7.320 10
PS(19:0/22:4(7Z,10Z,13Z,16Z)) 853.40 1.161 2.661 9 2.409 4.676 10
PS(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 850.75 0.518 0.765 6 1.764 4.276 10
PS(19:1(9Z)/0:0) 537.13 24.862 75.813 10 7.150 12.150 11
PS(19:1(9Z)/22:2(13Z,16Z)) 855.39 4.596 11.222 6 0.015 0.028 8
PS(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 851.24 0.548 1.217 5 0.017 0.026 7
PS(20:0/0:0) 553.41 0.396 0.885 9 8.530 19.933 9
PS(20:0/22:1(11Z)) 873.71 2.106 3.422 9 4.368 7.844 11
PS(20:0/22:2(13Z,16Z)) 871.14 4.032 5.113 6 1.057 2.442 9
PS(20:0/22:4(7Z,10Z,13Z,16Z)) 867.27 8.718 27.286 10 4.210 9.554 8
PS(20:1(11Z)/0:0) 550.66 13.324 39.480 9 3.039 6.632 8
PS(20:1(11Z)/22:2(13Z,16Z)) 869.87 69.469 138.936 4 0.014 0.026 7
PS(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 864.92 0.513 1.092 8 1.581 3.699 7
PS(20:2(11Z,14Z)/0:0) 548.71 14.673 39.436 8 2.673 4.847 8
PS(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) 863.52 0.067 0.144 5 0.070 0.106 3
PS(20:3(8Z,11Z,14Z)/0:0) 547.21 0.012 0.022 5 0.010 0.013 4
PS(20:4(5Z,8Z,11Z,14Z)/0:0) 545.30 0.632 1.077 8 1.795 3.555 11
PS(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) 542.68 1.175 2.547 9 1.743 3.577 10
PS(21:0/22:0) 890.27 17.791 46.132 9 5.824 12.928 11
PS(21:0/22:1(11Z)) 887.23 0.795 1.237 8 4.384 6.017 6
PS(21:0/22:2(13Z,16Z)) 886.01 0.015 0.032 5 0.008 0.013 9
PS(21:0/22:4(7Z,10Z,13Z,16Z)) 881.51 0.006 0.006 6 0.032 0.058 6
PS(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 877.03 21.475 62.548 10 3.874 8.378 11
PS(22:0/0:0) 581.67 5.742 13.122 9 2.343 6.665 9
PS(22:0/12:0) 763.49 49.430 85.605 3 0.020 0.031 7
PS(22:0/20:0) 875.54 122.401 367.169 9 0.003 0.003 5
PS(22:0/22:0) 904.27 19.779 41.841 5 2.977 5.175 9
PS(22:0/22:1(11Z)) 901.35 1.179 2.572 12 4.321 10.800 9
PS(22:0/22:2(13Z,16Z)) 899.03 6.641 14.948 8 0.221 0.445 8
PS(22:0/22:4(7Z,10Z,13Z,16Z)) 895.48 12.260 36.824 11 61.685 182.481 11
PS(22:1(11Z)/0:0) 579.17 12.091 33.589 9 6.625 15.877 11
PS(22:1(11Z)/22:2(13Z,16Z)) 897.05 0.006 0.001 3 0.289 0.453 3
PS(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 893.05 0.053 0.092 7 1.031 2.177 11
PS(22:2(13Z,16Z)/0:0) 576.53 1.683 2.940 6 2.988 7.055 10
PS(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)) 891.30 13.702 33.529 6 0.011 0.017 5
PS(22:4(7Z,10Z,13Z,16Z)/0:0) 572.96 6.590 15.633 8 7.168 15.826 8
PS(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 883.62 5.870 13.784 10 7.243 12.949 8
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) 569.10 10.243 19.982 4 5.887 13.082 8
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 989.32 15.548 40.094 8 4.092 9.654 11
PS(6:0/6:0) 455.36 1.092 2.237 8 4.007 7.778 13
PS(8:0/8:0) 511.24 0.611 1.435 10 3.446 7.101 11
*

The lipid species identification is based on Lipidmaps database, used as a *.csv file for bioinformatic analyses with MZmine 2.9 program.

**

A representative mass/charge ratio is presented (variations in m/z was reconciled by MZmine 2.9). Average standard non-normalized dataset is presented here. For some lipid species identified, standard error of mean could not be calculated due to lack of presence in all samples.

3.3 Phosphatidylethanolamines of AQH

There were 2 and 1 unique PE species identified in the control and glaucomatous (Table 1) AQH respectively while 142 species were common in both (Table 4). The most frequently observed unique PE species in control AQH were: PE-NMe2(O-16:0/O-16:0) found in 2 donors and PE(18:1(9E)/18:1(9E)) found in 7 donors. The most frequently occurring PE species observed in glaucomatous AQH was: PE(15:0/20:3(8Z,11Z,14Z)) found in 4 donors (Supplemental Tables S1 and S2).

Table 4.

Common lipid species between control and glaucomatous aqueous humor

Control
Glaucoma
Lipid Species* m/z** Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency Average normalized lipid amount (pmol per species/μg protein) Std. Dev. Donor Frequency
NAPE(18:1(9Z)/16:1(9Z)/18:0) 982.02 0.393 0.445 7 15.314 3.745 6
PE(10:0/10:0) 523.85 0.108 0.183 9 4.480 1.196 8
PE(12:0/12:0) 578.96 0.327 0.485 7 20.702 5.203 6
PE(12:0/13:0) 592.94 0.283 0.807 10 5.004 2.250 9
PE(12:0/14:0) 607.16 0.230 0.408 10 8.652 3.843 9
PE(12:0/14:1(9Z)) 604.84 0.147 0.317 7 3.784 1.312 13
PE(12:0/15:0) 621.85 16.320 48.772 9 6.821 2.404 7
PE(12:0/15:1(9Z)) 619.04 16.414 48.589 9 21.046 6.740 8
PE(12:0/16:1(9Z)) 633.11 0.463 1.373 9 8.101 2.074 9
PE(12:0/17:1(9Z)) 646.91 0.867 1.874 5 322.678 181.660 8
PE(12:0/17:2(9Z,12Z)) 645.18 25.608 61.944 6 13.918 2.531 7
PE(12:0/18:2(9Z,12Z)) 659.39 17.460 51.824 9 9.672 4.286 10
PE(12:0/18:3(6Z,9Z,12Z)) 657.41 0.031 0.051 3 8.600 2.976 6
PE(12:0/18:4(6Z,9Z,12Z,15Z)) 654.91 22.319 58.307 7 8.595 2.492 5
PE(12:0/19:0) 677.53 0.019 0.028 5 11.912 2.628 4
PE(12:0/20:1(11Z)) 689.67 42.689 79.976 4 29.109 11.348 4
PE(12:0/20:3(8Z,11Z,14Z)) 685.05 0.159 0.317 7 8.177 2.933 11
PE(12:0/20:4(5Z,8Z,11Z,14Z)) 683.19 23.112 60.751 7 19.401 6.775 6
PE(12:0/20:5(5Z,8Z,11Z,14Z,17Z)) 681.04 0.252 0.515 8 6.128 2.848 6
PE(12:0/22:4(7Z,10Z,13Z,16Z)) 711.01 16.823 53.012 10 4.484 2.499 11
PE(13:0/17:1(9Z)) 661.42 1.309 1.452 3 21.457 7.355 3
PE(13:0/18:2(9Z,12Z)) 673.13 26.699 64.594 6 6.330 2.270 8
PE(13:0/18:3(6Z,9Z,12Z)) 670.70 26.381 64.520 6 3.391 1.683 10
PE(13:0/18:4(6Z,9Z,12Z,15Z)) 668.64 0.526 1.066 7 7.379 3.114 8
PE(13:0/20:1(11Z)) 702.80 0.249 0.565 7 23.794 9.178 8
PE(13:0/20:2(11Z,14Z)) 701.28 16.750 52.158 10 19.506 4.921 6
PE(13:0/20:3(8Z,11Z,14Z)) 698.73 20.925 58.222 8 10.127 3.509 11
PE(13:0/20:4(5Z,8Z,11Z,14Z)) 697.01 0.295 0.600 6 12.809 6.174 11
PE(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) 694.97 21.040 57.837 8 13.718 4.529 7
PE(13:0/22:2(13Z,16Z)) 729.04 0.236 0.400 8 21.926 5.675 5
PE(13:0/22:4(7Z,10Z,13Z,16Z)) 725.81 19.198 57.021 9 25.298 3.972 6
PE(13:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 722.00 15.917 51.167 11 7.759 3.660 7
PE(14:0/0:0) 425.22 0.249 0.466 9 9.153 3.416 8
PE(14:1(9Z)/0:0) 422.49 14.334 37.629 7 15.242 7.280 9
PE(14:1(9Z)/14:1(9Z)) 631.57 0.033 0.065 5 22.889 6.255 7
PE(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 709.21 24.259 63.098 7 24.442 9.694 6
PE(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 707.68 56.067 95.783 3 0.126 0.041 5
PE(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 737.31 19.708 57.838 9 184.469 90.526 7
PE(15:0/0:0) 439.92 0.198 0.380 6 14.857 3.511 7
PE(15:0/15:0) 663.68 0.202 0.444 10 5.915 2.054 10
PE(15:0/20:5(5Z,8Z,11Z,14Z,17Z)) 723.60 28.426 69.611 6 4.521 2.011 5
PE(15:0/22:1(11Z)) 759.63 0.414 0.824 4 0.923 0.386 7
PE(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 750.38 0.200 0.383 6 8.114 2.366 5
PE(15:1(9Z)/0:0) 437.35 13.505 36.268 8 3.605 0.650 6
PE(15:1(9Z)/22:2(13Z,16Z)) 755.46 0.008 0.010 2 0.071 0.000 2
PE(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 751.63 0.976 1.555 4 25.386 11.048 6
PE(16:0/0:0) 453.26 11.954 35.530 9 3.529 0.910 8
PE(16:0/16:0) 691.36 0.126 0.186 9 167.619 74.217 6
PE(16:0/18:1(9Z)) 717.71 0.124 0.200 8 12.584 4.883 12
PE(16:0/18:2(9Z,12Z)) 715.37 0.767 0.776 3 0.147 0.035 3
PE(16:0/18:3(9Z,12Z,15Z)) 713.21 0.276 0.564 7 12.653 4.261 9
PE(16:0/20:4(5Z,8Z,11Z,14Z)) 739.07 0.315 0.540 4 102.423 55.374 9
PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 763.97 0.493 0.734 5 13.570 2.516 8
PE(16:1(9Z)/0:0) 450.68 21.570 47.373 5 19.296 5.901 8
PE(16:1(9Z)/16:1(9Z)) 687.28 0.295 0.474 9 11.506 2.925 9
PE(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)) 735.91 29.264 70.609 6 0.047 0.017 4
PE(16:1(9Z)/22:2(13Z,16Z)) 769.02 60.947 104.118 3 17.047 5.361 3
PE(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 765.87 30.390 73.583 6 0.202 0.073 4
PE(17:0/14:1(9Z)) 675.68 0.131 0.250 8 14.494 3.079 6
PE(17:0/20:0) 761.21 18.459 56.579 10 16.303 5.813 9
PE(17:0/20:4(5Z,8Z,11Z,14Z)) 753.61 0.500 0.687 9 20.141 6.116 7
PE(17:0/22:0) 789.02 62.205 186.106 9 19.943 7.369 10
PE(17:0/22:1(11Z)) 787.15 0.380 0.668 6 2.725 0.884 7
PE(17:0/22:2(13Z,16Z)) 785.18 0.348 0.673 6 5.591 1.359 7
PE(17:0/22:4(7Z,10Z,13Z,16Z)) 781.81 0.921 1.388 9 11.534 3.681 8
PE(17:1(9Z)/0:0) 464.71 0.185 0.350 8 6.163 1.406 5
PE(17:1(9Z)/22:2(13Z,16Z)) 783.56 30.933 75.416 6 0.298 0.108 4
PE(17:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 779.06 0.004 0.006 2 9.687 3.551 8
PE(17:2(9Z,12Z)/0:0) 462.32 0.018 0.020 7 6.919 2.290 7
PE(17:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)) 777.71 0.002 0.001 2 0.163 0.057 4
PE(18:0/0:0) 481.44 0.216 0.313 7 8.163 2.539 3
PE(18:0/10:0) 635.66 0.058 0.084 6 5.015 1.602 11
PE(18:0/18:0) 747.98 16.534 52.994 11 12.553 1.723 4
PE(18:0/18:1(9Z)) 745.61 0.412 0.805 4 5.266 1.639 4
PE(18:0/20:0) 775.28 0.634 1.659 9 186.743 107.624 9
PE(18:0/22:0) 803.28 0.236 0.312 10 15.228 4.133 6
PE(18:0/22:1(13Z)) 801.87 48.453 93.791 4 10.863 5.592 7
PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 791.81 0.368 0.625 7 13.519 6.242 10
PE(18:1(9Z)/0:0) 478.50 14.127 39.848 8 4.067 1.312 6
PE(18:1(9Z)/18:2(9Z,12Z)) 740.95 0.268 0.498 10 4.842 1.488 8
PE(18:1(9Z)/22:2(13Z,16Z)) 796.90 0.099 0.169 8 4.327 1.114 6
PE(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 794.16 21.060 62.200 9 5.727 1.957 8
PE(18:2(9Z,12Z)/0:0) 477.02 0.528 1.264 6 4.675 2.511 10
PE(18:2(9Z,12Z)/22:2(13Z,16Z)) 795.86 0.259 0.557 5 1.912 0.410 2
PE(18:3(6Z,9Z,12Z)/0:0) 475.01 12.621 37.217 9 9.447 2.588 7
PE(18:4(6Z,9Z,12Z,15Z)/0:0) 473.14 0.405 0.546 3 7.721 2.338 9
PE(19:0/0:0) 495.74 0.201 0.369 8 14.544 3.156 3
PE(19:0/16:0) 733.19 0.414 0.571 8 8.692 3.863 10
PE(19:0/22:1(11Z)) 814.99 0.596 0.829 6 38.991 17.638 8
PE(19:0/22:2(13Z,16Z)) 813.46 76.689 171.427 5 8.734 2.084 4
PE(19:0/22:4(7Z,10Z,13Z,16Z)) 808.97 0.478 1.227 8 25.247 8.903 5
PE(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 805.98 0.043 0.070 5 14.766 2.986 5
PE(19:1(9Z)/0:0) 493.49 14.783 41.043 8 29.666 13.434 10
PE(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) 807.46 48.039 94.900 4 16.709 8.738 7
PE(20:0/0:0) 509.16 17.209 45.354 7 17.323 4.695 8
PE(20:0/18:1(9Z)) 773.76 0.122 0.271 5 23.504 10.423 5
PE(20:0/18:4(6Z,9Z,12Z,15Z)) 767.80 0.313 0.601 11 28.568 9.542 7
PE(20:0/20:2(11Z,14Z)) 800.16 0.076 0.170 8 162.637 98.288 10
PE(20:0/22:0) 830.70 0.082 0.098 4 4.729 1.896 6
PE(20:0/22:1(13Z)) 829.53 39.376 123.634 10 6.045 2.446 8
PE(20:0/22:2(13Z,16Z)) 827.32 0.279 0.625 8 8.065 3.495 6
PE(20:0/22:4(7Z,10Z,13Z,16Z)) 824.02 0.580 0.843 8 12.851 4.791 8
PE(20:0/24:1(15Z)) 857.00 0.758 1.458 6 3.280 1.212 8
PE(20:1(11Z)/0:0) 507.06 0.004 0.004 6 3.488 1.096 8
PE(20:1(11Z)/22:2(13Z,16Z)) 825.56 0.025 0.042 3 0.155 0.037 3
PE(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 821.36 0.303 0.567 10 14.272 4.291 8
PE(20:2(11Z,14Z)/0:0) 504.92 0.184 0.375 8 3.974 1.022 5
PE(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) 819.37 0.002 0.001 3 19.078 9.249 6
PE(20:2(5Z,8Z)/18:0) 771.63 20.378 60.608 9 7.438 2.050 6
PE(20:3(8Z,11Z,14Z)/0:0) 503.09 0.291 0.474 5 0.304 0.078 8
PE(20:4(5Z,8Z,11Z,14Z)/0:0) 501.02 0.261 0.402 10 8.852 2.163 4
PE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) 498.99 15.159 41.412 8 128.071 56.383 5
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)) 811.39 0.594 1.194 8 13.233 6.108 8
PE(21:0/22:0) 846.28 0.066 0.070 8 13.879 3.486 9
PE(21:0/22:1(11Z)) 843.01 20.087 62.855 10 10.644 4.309 9
PE(21:0/22:2(13Z,16Z)) 840.94 1.274 2.958 6 21.590 5.792 6
PE(21:0/22:4(7Z,10Z,13Z,16Z)) 837.78 0.063 0.174 9 12.509 2.129 4
PE(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 833.18 20.265 61.978 10 18.894 5.912 10
PE(22:0/0:0) 538.14 18.205 47.906 7 7.693 2.855 9
PE(22:0/22:2(13Z,16Z)) 855.37 0.358 0.738 6 4.773 1.734 10
PE(22:0/22:4(7Z,10Z,13Z,16Z)) 851.60 0.530 0.783 10 14.149 3.264 8
PE(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 848.28 0.068 0.137 7 12.242 3.724 8
PE(22:0/24:1(15Z)) 885.70 41.916 132.031 10 22.426 8.445 12
PE(22:1(11Z)/0:0) 535.35 11.708 37.992 11 18.256 5.722 7
PE(22:1(11Z)/22:2(13Z,16Z)) 853.55 80.900 179.853 5 0.359 0.117 5
PE(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) 849.31 1.419 1.984 3 0.250 0.060 4
PE(22:2(13Z,16Z)/0:0) 532.87 0.008 0.012 6 21.149 4.154 3
PE(22:4(7Z,10Z,13Z,16Z)/0:0) 528.67 0.098 0.117 5 9.333 3.256 8
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) 525.52 0.253 0.441 6 3.379 1.231 5
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)) 839.97 99.053 140.035 2 0.160 0.041 7
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 835.94 22.368 65.446 9 6.881 3.067 9
PE(24:0/20:0) 859.43 0.261 0.338 10 27.241 8.803 7
PE(26:2(5Z,9Z)/26:2(5Z,9Z)) 963.91 0.224 0.252 8 40.849 14.566 6
PE(6:0/6:0) 410.48 0.107 0.106 6 16.191 6.129 8
PE(8:0/8:0) 466.92 55.131 134.960 6 2.633 0.716 10
PE-NMe(11:0/11:0) 565.43 27.749 83.976 10 11.077 2.790 7
PE-NMe(14:0/14:0) 649.62 0.305 0.487 10 16.438 7.003 12
PE-NMe(16:0/16:0) 705.83 0.588 1.119 7 6.917 2.425 11
PE-NMe(16:0/18:1(9Z)) 731.41 25.149 65.042 7 0.881 0.332 4
PE-NMe(18:1(9E)/18:1(9E)) 758.00 20.386 59.385 9 13.268 4.494 7
PE-NMe(20:0/20:0) 817.96 24.251 68.068 8 79.995 39.241 10
PE-NMe2(16:0/16:0) 720.03 0.041 0.066 7 29.559 6.342 5
*

The lipid species identification is based on Lipidmaps database, used as a *.csv file for bioinformatic analyses with MZmine 2.9 program.

**

A representative mass/charge ratio is presented (variations in m/z was reconciled by MZmine 2.9). Average standard non-normalized dataset is presented here. For some lipid species identified, standard error of mean could not be calculated due to lack of presence in all samples.

3.4 Phosphatidylinositols of AQH

One unique PI species was identified in the control AQH while two unique PI species were identified in the glaucomatous AQH (Table 1). There were 134 PI species in common between control and POAG AQH tissues (Table 5). The most frequently observed unique PI species in the control AQH were: PI(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) found in 6 donors. The most frequently occurring unique PI species in glaucomatous AQH were: PI(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)) found in 6 donors and PI(O-18:0/0:0) found in 3 donors (Supplemental Tables S1and S2).

4. Discussion

AQH outflow is impeded secondary to increased trabecular meshwork resistance in POAG [13], resulting in elevated IOP, which in turn, causes optic nerve damage. The factor that increases resistance at the TM in POAG remains poorly understood. Whether factors exist in the AQH that baths TM and affects TM cells behavior remains to be discovered. Initially characterized as smooth muscle contracting substrates, prostaglandin (PG) lipids were identified in the iris and these substances were collectively named irin in 1955 [13]. PG lipid analogs were subsequently found to be one of the most effective IOP reducing entities [33, 34]. However, the effects of other classes of lipids on IOP or outflow facility have just begun to be studied. A relationship between intraocular and systemic blood pressures is thought to exist and is potentially responsible for influencing the onset and/or the progression of POAG [35]. Vascular factors such as decreased optic nerve blood velocity and increased red blood cell aggregation have been thought to influence the progression of POAG by increasing intraocular pressure. These factors are influenced by lipids [36]. Findings such as significantly reduced levels of red blood cell and plasma eicosapentaenoic acid (EPA) as well as docosahexaenoic acid (DHA) compared with healthy patients may explain increased erythrocyte lipid membrane rigidity and aggregation observed in POAG patients. POAG patients had reduced phosphatidylcholine (PC) complexed DHA in erythrocytes [37]. Glaucoma patients are thought to have enhanced platelet aggregation, which impaires ocular blood flow. The EPA is a precursor of the vasodilator, anti-aggregatory and anti-inflammatory eicosanoids [36]. Regular intake of omega-3 fats is of fundamental importance to ocular health and supplementing the diet with EPA/DHA has been shown to reduce intraocular pressure in experimental animals [38, 39]. Also, lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) decrease aqueous humor outflow, indicating non – PG lipids are involved in regulation of AQH outflow as well [40]. As lysophospholipids have been implicated in aqueous outflow and in damage processes [41], we analyzed lysophosolipid to phospholipid ratios in AQH of control and POAG donors for total lipids (Supplementary Figure 1A) as well as for each class of phospholipids (Supplemental Fig. 1B–E). The lysophospholipid as a percent of total phospholipids indeed increases in glaucoma (Supplemental Fig. 1A) consistent with the possibility of their involvement in the damage process. This increase is mostly attributed to level of phosphatidylserines and phosphatidylethanolamines (Supplemental Fig. 1C and D). In contrast the lysoPC and lysoPI levels are higher in controls than in glaucoma (Supplemental Fig. 1B and E). The existence of members of all lipid classes and that of the lysophospholipids in the AQH remains to be investigated. The identification, quantification, and their changes in POAG will help investigate the roles select identified lipids play in TM cell biology.

Phospholipids are the main components of the membrane lipid bilayer that assist in creating cell boundaries as well as integrity of the cells for life processes. It is membrane phospholipids that create a hydrophobic environment for transmembrane protein function and communication. Some membrane lipids are part of lipid second messengers which are metabolized by enzymatic activity from phospholipid precursors [42]. However, there is increasing evidence that phospholipids may have a much larger role in the regulation of ocular mechanisms because of their presence in the aqueous humor and their subsequent changes under injurious circumstances. Studies have shown that growth factor-like glycerophosphate mediators of the LPA class are present in AQH as well as the lacrimal gland of a rabbit eye, and corneal injury has resulted in the increased production of these mediators [43]. In the AQH itself, alkenyl-glycerophosphate has been identified in post injury AQH [43]. Lysophospholipase D (LysoPLD) activity of autotaxin was found significantly elevated in the aqueous humor of POAG patients in comparison with control aqueous humor, which suggests a high level of mechanistic importance in phospholipids in the aqueous humor [44]. Corneal wounds in rabbit eyes have shown a high enzyme activity of plasma lysoPLD, or autotaxin in both control and injured rabbit corneal tissue. However, levels of lysophosphatidycholines were several times higher in injured corneal AQH samples in comparison with control AQH samples, suggesting that lysoPLD is released from corneal tissues into the AQH [45]. In addition, phosphatidylinositol (PIs) are one of the known classes of phospholipids undergoing significant changes during the administration of PG analogs for IOP lowering [46, 47]. Recent studies have also shown a significant difference in phospholipid species between human POAG and control trabecular meshwork tissue [48], yet the differences in phospholipid profiles in POAG AQH and control AQH have yet to be studied in further detail.

Endogenous lipids in the anterior chamber may be involved in regulation of aqueous outflow, outflow facility and IOP. The previous techniques such as various forms of chromatography and nuclear magnetic resonance necessitated (1) knowledge of several different chemistries due to different chemical behavior of different lipid species even within a class and, (2) requirement of large amounts (microgram quantities) of lipids for identification and characterization. Recent advances in mass spectrometry enable overcoming these two greatest hurdles towards high throughput determination of identities of phospholipids of all four classes (PC, PS, PE and PI) in the AQH. We have determined the endogenous phospholipids present in AQH using triple quadrupole mass spectrometry in precursor ion and neutral loss scan modes with parameters that have been well established in the lipid field [20]. Using these methods, we present two phospholipid species that have been determined as statistically significantly different; PC(16:0/26:2(5Z,9Z)) found in 4 control and 10 POAG donor AQH (Table 2) and PI(15:0/22:0) found in 8 control and 7 POAG donor AQH (Table 5). The same phosphatidylcholine and phosphatidylinositol species were found in the TM of control and POAG donor tissues [48]. Control and POAG TM tissues have little difference in the amount of PC(16:0/26:2(5Z,9Z)); however, control and POAG AQH have a significant difference, with the control AQH having a much higher amount than POAG. PI(15:0/22:0) was found in a much higher amount in control AQH, than in POAG AQH, but in much lower amounts in control TM than in POAG TM. Data suggests these phosphatidylcholine and phosphatidylinositol species undergoes a switch in average amounts in correlation with the development of POAG, which alludes to PC(16:0/26:2(5Z,9Z)) and PI(15:0/22:0) moving into the AQH from the TM under normal physiological conditions, but their inhibited movement with development of POAG. These results allude to a possibility of an unnatural buildup of PC(16:0/26:2(5Z,9Z)) and PI(15:0/22:0) in POAG TM, and thus, much lower amounts in the AQH. Further investigation of whether PI(15:0/22:0) and PC(16:0/26:2(5Z,9Z)) are limited to the TM-AQH system and how exactly these phospholipids come to appear in two different tissues remains pure speculation at the present moment but are important questions for future experimentation.

In the current investigation, all AQH samples were collected locally, frozen immediately and were stored at −80°C until used for analyses. AQH samples were subjected to only one thawing cycle prior to their use. Our control analyses with cornea and other anterior chamber tissue/fluids from mammalian model systems (porcine, bovine and a select subset of humans) showed a decrease of phospholipid species but no selective absence or appearance of a phospholipid species as a function of storage up to a week at 4°C in PBS or Optisol GS [49] and no alteration when immediately stored in −80°C and thawed only once (Bhattacharya, SK and Aribindi, K.; unpublished observations), our observations parallels that for mass spectrometric analyses of serum [50], where repeated freeze-thaw cycles have been previously shown to affect small molecules and peptides. AQH is likely to provide an accurate depiction into the differential lipid profile between control and diseased samples because of the local control of sample from collection to analyses. Three other factors are intrinsically likely to broadly affect the lipid profiles apart from biochemical individuality of the donors: (a) confounding factors of diseases or disorders that are well known to affect lipid profiles such as hyperlipidemia, (b) use of drugs by the donors such as statins and (c) confounding factors of diseases that are per se not lipid related such as diabetes. Previously, use of statins have found not to affect the phospholipid profiles in the lens and conjectured not to affect that in the ocular tissues [51]. Careful analyses of statin users reflect very little changes in phospholipids systemically [52] supporting that phospholipids are probably not significantly affected in statin users. Nevertheless, information as to whether or not a donor was on statins has been provided for the phospholipid species that were classified as unique identifications.

The triple quadrupole instrument used here has a resolution of 1 atomic mass unit (at 0.7FWHM), which is a first pass attempt to profile all phospholipid species. Further high-resolution mass spectrometry will enable these identifications with greater conformity. In the future, the unique species identified here will need to be carefully characterized using different collision energies and high-resolution mass spectrometry. A comprehensive comparison between TM and AQH, along with other tissues including blood and optic nerve will provide insight about systematic and local changes occurring in glaucoma as well as complications from confounding factors. A possibility of an applied outcome from this research also looms in the horizon. Continued research in PG analogs beyond their original discovery in the iris [13] led to their development as effective IOP reducing topical medications like latanoprost and travoprost [53]. Lowering IOP by increasing the outflow via the conventional pathway will be close to normal physiology [54, 55]. Apart from pilocarpine, a muscarinic agonist of inferior efficacy compared to prostaglandins with significant side-effects, no other drugs are available to enhance aqueous outflow via the TM pathway. The development of additional IOP lowering drugs, especially those through which aqueous drainage is increased via the conventional outflow pathway, is needed. Endogenous lipids other than prostaglandins present in the AQH might have some potential in this direction and only future continued research will reveal whether this is a viable possibility.

In conclusion, future work will reveal biological consequences of local alteration of phospholipids in the AQH as well as the TM region and insight into their contribution in pathology. Profiling of lipids is also expected to help expand databases (perhaps infinitesimally incremental) enabling the synthesis of interesting lipid species and their screening to determine the biological roles that they might play in the anterior segment of the eye.

Supplementary Material

01

Highlights.

  • Phospholipid profile comparison of human control and glaucomatous aqueous humor.

  • Mass spectrometric showed several phospholipid species common between them.

  • A number of unique lipid species in four phospholipid classes were also identified.

  • Some were uniquely present in control, but absent in glaucomatous and vice versa.

Acknowledgments

This work was partly supported by NIH grants EY016112, P30-EY14801, the Computational Ocular Genomics Training Grant T32EY023194-01 (to GE), a Research to Prevent Blindness (RPB) Career Development Award (to SKB) and a RPB unrestricted grant to University of Miami. The TSQ Quantum Access Max procurement was supported by Department of Defense Grant W81XWH-09-1-0674. We thank Dr. Bogdan Gugiu for his insightful comments during study design and Mitchell Martinez for assistance with mass spectrometry.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267. doi: 10.1136/bjo.2005.081224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–1720. doi: 10.1016/S0140-6736(04)16257-0. [DOI] [PubMed] [Google Scholar]
  • 3.Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134–142. doi: 10.1097/00061198-200004000-00002. [DOI] [PubMed] [Google Scholar]
  • 4.Morrison JC, Acott TS. Anatomy and physiology of aqueous humor outflow. In: Morrison JC, Pollack IP, editors. Glaucoma Science and Practice. Thieme Medical Publishers Inc; New York: 2003. pp. 34–41. [Google Scholar]
  • 5.Krupin T, Wax M, Moolchandani J. Aqueous production. Trans Ophthalmol Soc U K. 1986;105(Pt 2):156–161. [PubMed] [Google Scholar]
  • 6.Gobel K, Rufer F, Erb C. Physiology of aqueous humor formation, diurnal fluctuation of intraocular pressure and its significance for glaucoma. Klin Monbl Augenheilkd. 2011;228:104–108. doi: 10.1055/s-0029-1246040. [DOI] [PubMed] [Google Scholar]
  • 7.Acott TS, Kelley MJ. Extracellular matrix in the trabecular meshwork. Exp Eye Res. 2008;86:543–561. doi: 10.1016/j.exer.2008.01.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tektas OY, Lutjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res. 2009;88:769–775. doi: 10.1016/j.exer.2008.11.025. [DOI] [PubMed] [Google Scholar]
  • 9.Last JA, Pan T, Ding Y, Reilly CM, Keller K, Acott TS, Fautsch MP, Murphy CJ, Russell P. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 2011;52:2147–2152. doi: 10.1167/iovs.10-6342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McKee CT, Wood JA, Shah NM, Fischer ME, Reilly CM, Murphy CJ, Russell P. The effect of biophysical attributes of the ocular trabecular meshwork associated with glaucoma on the cell response to therapeutic agents. Biomaterials. 2011;32:2417–2423. doi: 10.1016/j.biomaterials.2010.11.071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Russell P, Johnson M. Elastic modulus determination of normal and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 2012;53:117. doi: 10.1167/iovs.11-9314. [DOI] [PubMed] [Google Scholar]
  • 12.Gong H, Tripathi RC, Tripathi BJ. Morphology of the aqueous outflow pathway. Microsc Res Tech. 1996;33:336–367. doi: 10.1002/(SICI)1097-0029(19960301)33:4<336::AID-JEMT4>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  • 13.Ambache N. Irin, a smooth-muscle contracting substance present in rabbit iris. J Physiol. 1955;129:65–66P. doi: 10.1113/jphysiol.1955.sp005387. [DOI] [PubMed] [Google Scholar]
  • 14.Ambache N. Properties of irin, a physiological constituent of the rabbit’s iris. J Physiol. 1957;135:114–132. doi: 10.1113/jphysiol.1957.sp005699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ambache N. The unsaturated nature of irin and its interaction with lactones. J Physiol. 1958;140:24–25P. [PubMed] [Google Scholar]
  • 16.Ambache N. Further studies on the preparation, purification and nature of irin. J Physiol. 1959;146:255–294. doi: 10.1113/jphysiol.1959.sp006193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ambache N. Irin and a hydroxy-acid from brain. Biochem Pharmacol. 1963;12:421–428. doi: 10.1016/0006-2952(63)90075-3. [DOI] [PubMed] [Google Scholar]
  • 18.Ambache N, Kavanagh L, Whiting J. Some differences in uveal reactions between cats and rabbits. J Physiol. 1966;182:110–130. doi: 10.1113/jphysiol.1966.sp007812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47(Suppl 1):S53–64. doi: 10.1016/s0039-6257(02)00306-5. [DOI] [PubMed] [Google Scholar]
  • 20.Yang K, Cheng H, Gross RW, Han X. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal Chem. 2009;81:4356–4368. doi: 10.1021/ac900241u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Schwudke D, Schuhmann K, Herzog R, Bornstein SR, Shevchenko A. Shotgun Lipidomics on High Resolution Mass Spectrometers. Cold Spring Harb Perspect Biol. 2011 doi: 10.1101/cshperspect.a004614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol. 2010;11:593–598. doi: 10.1038/nrm2934. [DOI] [PubMed] [Google Scholar]
  • 23.Yang K, Zhao Z, Gross RW, Han X. Identification and quantitation of unsaturated fatty acid isomers by electrospray ionization tandem mass spectrometry: a shotgun lipidomics approach. Anal Chem. 2011;83:4243–4250. doi: 10.1021/ac2006119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bhattacharya SK. Recent advances in shotgun lipidomics and their implication for vision research and ophthalmology. Curr Eye Res. 2013;38:417–427. doi: 10.3109/02713683.2012.760742. [DOI] [PubMed] [Google Scholar]
  • 25.Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  • 26.Aribindi K, Guerra Y, Lee RK, Bhattacharya SK. Comparative Phospholipid Profiles of Control and Glaucomatous Human Trabecular Meshwork. Invest Ophthalmol Vis Sci. 2013;54:3037–3044. doi: 10.1167/iovs.12-10517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  • 28.Amelinckx A, Castello M, Arrieta-Quintero E, Lee T, Salas N, Hernandez E, Lee RK, Bhattacharya SK, Parel JM. Laser trabeculoplasty induces changes in the trabecular meshwork glycoproteome: a pilot study. J Proteome Res. 2009;8:3727–3736. doi: 10.1021/pr900294g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hunziker P, Andersen TT, Bao Y, Cohen SA, Denslow ND, Hulmes JD, Mahrenholz AM, Mann K, Schegg KM, West KA, Crabb JW. Identification of proteins electroblotted to polyvinylidene difluoride membrane by combined amino acid analysis and bioinformatics: An ABRF multicenter study. J Biomol Tech. 1999;10:129–136. [PMC free article] [PubMed] [Google Scholar]
  • 30.Aribindi K, Guerra Y, Piqueras MC, Banta JT, Lee RK, Bhattacharya SK. Cholesterol and Glycosphingolipids of Human Trabecular Meshwork and Aqueous humor: Comparative Profiles from control and glaucomatous donors. Curr Eye Res. 2013;38:1017–1026. doi: 10.3109/02713683.2013.803123. [DOI] [PubMed] [Google Scholar]
  • 31.Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev. 2011 doi: 10.1002/mas.20342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010;11:395. doi: 10.1186/1471-2105-11-395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hejkal TW, Camras CB. Prostaglandin analogs in the treatment of glaucoma. Semin Ophthalmol. 1999;14:114–123. doi: 10.3109/08820539909061464. [DOI] [PubMed] [Google Scholar]
  • 34.Wax MB, Camras CB, Fiscella RG, Girkin C, Singh K, Weinreb RN. Emerging perspectives in glaucoma: optimizing 24-hour control of intraocular pressure. Am J Ophthalmol. 2002;133(Suppl):S1–10. doi: 10.1016/s0002-9394(02)01459-9. [DOI] [PubMed] [Google Scholar]
  • 35.McLeod SD, West SK, Quigley HA, Fozard JL. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci. 1990;31:2361–2366. [PubMed] [Google Scholar]
  • 36.Ren H, Magulike N, Ghebremeskel K, Crawford M. Primary open-angle glaucoma patients have reduced levels of blood docosahexaenoic and eicosapentaenoic acids. Prostaglandins Leukot Essent Fatty Acids. 2006;74:157–163. doi: 10.1016/j.plefa.2005.11.007. [DOI] [PubMed] [Google Scholar]
  • 37.Acar N, Berdeaux O, Juaneda P, Gregoire S, Cabaret S, Joffre C, Creuzot-Garcher CP, Bretillon L, Bron AM. Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma. Exp Eye Res. 2009;89:840–853. doi: 10.1016/j.exer.2009.07.008. [DOI] [PubMed] [Google Scholar]
  • 38.Popadiuk S, Korzon M, Chybicka A, Szmyd K, Dzierzega M, Trelinska J, Kowalczyk JR, Wisniewska-Slusarz H, Wozniak W, Bilska K, Wachowiak J, Konatkowska B, Wysocki M, Krawczuk-Rybak M, Czauderna P, Szumera M, Sznurkowska K, Renke J. Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland. Med Wieku Rozwoj. 2006;10:803–810. [PubMed] [Google Scholar]
  • 39.Mancino M, Ohia E, Kulkarni P. A comparative study between cod liver oil and liquid lard intake on intraocular pressure on rabbits. Prostaglandins Leukot Essent Fatty Acids. 1992;45:239–243. doi: 10.1016/0952-3278(92)90120-8. [DOI] [PubMed] [Google Scholar]
  • 40.Mettu PS, Deng PF, Misra UK, Gawdi G, Epstein DL, Rao PV. Role of lysophospholipid growth factors in the modulation of aqueous humor outflow facility. Invest Ophthalmol Vis Sci. 2004;45:2263–2271. doi: 10.1167/iovs.03-0960. [DOI] [PubMed] [Google Scholar]
  • 41.Meyer zu Heringdorf D, Jakobs KH. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim Biophys Acta. 2007;1768:923–940. doi: 10.1016/j.bbamem.2006.09.026. [DOI] [PubMed] [Google Scholar]
  • 42.Han X, Gross RW. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev. 2005;24:367–412. doi: 10.1002/mas.20023. [DOI] [PubMed] [Google Scholar]
  • 43.Liliom K, Guan Z, Tseng JL, Desiderio DM, Tigyi G, Watsky MA. Growth factor-like phospholipids generated after corneal injury. The American journal of physiology. 1998;274:C1065–1074. doi: 10.1152/ajpcell.1998.274.4.C1065. [DOI] [PubMed] [Google Scholar]
  • 44.Clark AG, Eisen MB, Smith DR, Bergman CM, Oliver B, Markow TA, Kaufman TC, Kellis M, Gelbart W, Iyer VN, Pollard DA, Sackton TB, Larracuente AM, Singh ND, Abad JP, Abt DN, Adryan B, Aguade M, Akashi H, Anderson WW, Aquadro CF, Ardell DH, Arguello R, Artieri CG, Barbash DA, Barker D, Barsanti P, Batterham P, Batzoglou S, Begun D, Bhutkar A, Blanco E, Bosak SA, Bradley RK, Brand AD, Brent MR, Brooks AN, Brown RH, Butlin RK, Caggese C, Calvi BR, Bernardo de Carvalho A, Caspi A, Castrezana S, Celniker SE, Chang JL, Chapple C, Chatterji S, Chinwalla A, Civetta A, Clifton SW, Comeron JM, Costello JC, Coyne JA, Daub J, David RG, Delcher AL, Delehaunty K, Do CB, Ebling H, Edwards K, Eickbush T, Evans JD, Filipski A, Findeiss S, Freyhult E, Fulton L, Fulton R, Garcia AC, Gardiner A, Garfield DA, Garvin BE, Gibson G, Gilbert D, Gnerre S, Godfrey J, Good R, Gotea V, Gravely B, Greenberg AJ, Griffiths-Jones S, Gross S, Guigo R, Gustafson EA, Haerty W, Hahn MW, Halligan DL, Halpern AL, Halter GM, Han MV, Heger A, Hillier L, Hinrichs AS, Holmes I, Hoskins RA, Hubisz MJ, Hultmark D, Huntley MA, Jaffe DB, Jagadeeshan S, Jeck WR, Johnson J, Jones CD, Jordan WC, Karpen GH, Kataoka E, Keightley PD, Kheradpour P, Kirkness EF, Koerich LB, Kristiansen K, Kudrna D, Kulathinal RJ, Kumar S, Kwok R, Lander E, Langley CH, Lapoint R, Lazzaro BP, Lee SJ, Levesque L, Li R, Lin CF, Lin MF, Lindblad-Toh K, Llopart A, Long M, Low L, Lozovsky E, Lu J, Luo M, Machado CA, Makalowski W, Marzo M, Matsuda M, Matzkin L, McAllister B, McBride CS, McKernan B, McKernan K, Mendez-Lago M, Minx P, Mollenhauer MU, Montooth K, Mount SM, Mu X, Myers E, Negre B, Newfeld S, Nielsen R, Noor MA, O’Grady P, Pachter L, Papaceit M, Parisi MJ, Parisi M, Parts L, Pedersen JS, Pesole G, Phillippy AM, Ponting CP, Pop M, Porcelli D, Powell JR, Prohaska S, Pruitt K, Puig M, Quesneville H, Ram KR, Rand D, Rasmussen MD, Reed LK, Reenan R, Reily A, Remington KA, Rieger TT, Ritchie MG, Robin C, Rogers YH, Rohde C, Rozas J, Rubenfield MJ, Ruiz A, Russo S, Salzberg SL, Sanchez-Gracia A, Saranga DJ, Sato H, Schaeffer SW, Schatz MC, Schlenke T, Schwartz R, Segarra C, Singh RS, Sirot L, Sirota M, Sisneros NB, Smith CD, Smith TF, Spieth J, Stage DE, Stark A, Stephan W, Strausberg RL, Strempel S, Sturgill D, Sutton G, Sutton GG, Tao W, Teichmann S, Tobari YN, Tomimura Y, Tsolas JM, Valente VL, Venter E, Venter JC, Vicario S, Vieira FG, Vilella AJ, Villasante A, Walenz B, Wang J, Wasserman M, Watts T, Wilson D, Wilson RK, Wing RA, Wolfner MF, Wong A, Wong GK, Wu CI, Wu G, Yamamoto D, Yang HP, Yang SP, Yorke JA, Yoshida K, Zdobnov E, Zhang P, Zhang Y, Zimin AV, Baldwin J, Abdouelleil A, Abdulkadir J, Abebe A, Abera B, Abreu J, Acer SC, Aftuck L, Alexander A, An P, Anderson E, Anderson S, Arachi H, Azer M, Bachantsang P, Barry A, Bayul T, Berlin A, Bessette D, Bloom T, Blye J, Boguslavskiy L, Bonnet C, Boukhgalter B, Bourzgui I, Brown A, Cahill P, Channer S, Cheshatsang Y, Chuda L, Citroen M, Collymore A, Cooke P, Costello M, D’Aco K, Daza R, De Haan G, DeGray S, DeMaso C, Dhargay N, Dooley K, Dooley E, Doricent M, Dorje P, Dorjee K, Dupes A, Elong R, Falk J, Farina A, Faro S, Ferguson D, Fisher S, Foley CD, Franke A, Friedrich D, Gadbois L, Gearin G, Gearin CR, Giannoukos G, Goode T, Graham J, Grandbois E, Grewal S, Gyaltsen K, Hafez N, Hagos B, Hall J, Henson C, Hollinger A, Honan T, Huard MD, Hughes L, Hurhula B, Husby ME, Kamat A, Kanga B, Kashin S, Khazanovich D, Kisner P, Lance K, Lara M, Lee W, Lennon N, Letendre F, LeVine R, Lipovsky A, Liu X, Liu J, Liu S, Lokyitsang T, Lokyitsang Y, Lubonja R, Lui A, MacDonald P, Magnisalis V, Maru K, Matthews C, McCusker W, McDonough S, Mehta T, Meldrim J, Meneus L, Mihai O, Mihalev A, Mihova T, Mittelman R, Mlenga V, Montmayeur A, Mulrain L, Navidi A, Naylor J, Negash T, Nguyen T, Nguyen N, Nicol R, Norbu C, Norbu N, Novod N, O’Neill B, Osman S, Markiewicz E, Oyono OL, Patti C, Phunkhang P, Pierre F, Priest M, Raghuraman S, Rege F, Reyes R, Rise C, Rogov P, Ross K, Ryan E, Settipalli S, Shea T, Sherpa N, Shi L, Shih D, Sparrow T, Spaulding J, Stalker J, Stange-Thomann N, Stavropoulos S, Stone C, Strader C, Tesfaye S, Thomson T, Thoulutsang Y, Thoulutsang D, Topham K, Topping I, Tsamla T, Vassiliev H, Vo A, Wangchuk T, Wangdi T, Weiand M, Wilkinson J, Wilson A, Yadav S, Young G, Yu Q, Zembek L, Zhong D, Zimmer A, Zwirko Z, Alvarez P, Brockman W, Butler J, Chin C, Grabherr M, Kleber M, Mauceli E, MacCallum I. Evolution of genes and genomes on the Drosophila phylogeny. Nature. 2007;450:203–218. doi: 10.1038/nature06341. [DOI] [PubMed] [Google Scholar]
  • 45.Tsuboi K, Okamoto Y, Ikematsu N, Inoue M, Shimizu Y, Uyama T, Wang J, Deutsch DG, Burns MP, Ulloa NM, Tokumura A, Ueda N. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta. 2011;1811:565–577. doi: 10.1016/j.bbalip.2011.07.009. [DOI] [PubMed] [Google Scholar]
  • 46.Yousufzai SY, Abdel-Latif AA. Tyrosine kinase inhibitors suppress prostaglandin F2alpha-induced phosphoinositide hydrolysis, Ca2+ elevation and contraction in iris sphincter smooth muscle. Eur J Pharmacol. 1998;360:185–193. doi: 10.1016/s0014-2999(98)00697-9. [DOI] [PubMed] [Google Scholar]
  • 47.Yorio T. Cellular mechanisms in the actions of antiglaucoma drugs. J Ocul Pharmacol. 1985;1:397–422. doi: 10.1089/jop.1985.1.397. [DOI] [PubMed] [Google Scholar]
  • 48.Aribindi K, Guerra Y, Lee RK, Bhattacharya SK. Comparative Phospholipid Profiles of Control and Glaucomatous Human Trabecular Meshwork. Invest Ophthalmol Vis Sci. 2013 doi: 10.1167/iovs.12-10517. In press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Crane AM, Hua HU, Coggin AD, Gugiu BG, Lam BL, Bhattacharya SK. Mass spectrometric analyses of phosphatidylcholines in alkali-exposed corneal tissue. Invest Ophthalmol Vis Sci. 2012;53:7122–7130. doi: 10.1167/iovs.12-10448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res. 2005;4:1060–1072. doi: 10.1021/pr050034b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Murawski U, Hockwin O. Lipid analysis in bovine lens parts after in vitro incubation in the presence of an HMG-CoA-reductase inhibitor. Lens Eye Toxic Res. 1990;7:593–603. [PubMed] [Google Scholar]
  • 52.Laaksonen R, Katajamaa M, Paiva H, Sysi-Aho M, Saarinen L, Junni P, Lutjohann D, Smet J, Van Coster R, Seppanen-Laakso T, Lehtimaki T, Soini J, Oresic M. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS One. 2006;1:e97. doi: 10.1371/journal.pone.0000097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Faulkner R, Sharif NA, Orr S, Sall K, Dubiner H, Whitson JT, Moster M, Craven ER, Curtis M, Pailliotet C, Martens K, Dahlin D. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN. Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics. 2010;26:147–156. doi: 10.1089/jop.2009.0098. [DOI] [PubMed] [Google Scholar]
  • 54.Bill A, Phillips CI. Uveoscleral drainage of aqueous humour in human eyes. Exp Eye Res. 1971;12:275–281. doi: 10.1016/0014-4835(71)90149-7. [DOI] [PubMed] [Google Scholar]
  • 55.Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol. 2008;53(Suppl 1):S107–120. doi: 10.1016/j.survophthal.2008.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES